{
  "entities": [
    {
      "id": "E1",
      "type": "Study",
      "name": "Bhat et al. 2020",
      "attributes": {
        "year": 2020,
        "doi": "https://doi.org/10.1016/j.phrs.2020.105078"
      },
      "source_chunk_ids": [
        "2770cefdbe076e2318d24742c304acb2"
      ],
      "confidence": 0.95,
      "evidence": "Bhat A, Ray B, Mahalakshmi AM, Tuladhar S, Nandakumar D, Srinivasan M, Essa MM, Chidambaram SB, Guillemain GJ, Sakharkar MK, Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders, Pharmacological Research (2020)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "review article",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "2770cefdbe076e2318d24742c304acb2"
      ],
      "confidence": 0.8,
      "evidence": "Please cite this article as",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "Phosphodiesterase-4 enzyme",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2770cefdbe076e2318d24742c304acb2"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase-4 enzyme as a therapeutic target",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "neurological disorders",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "2770cefdbe076e2318d24742c304acb2"
      ],
      "confidence": 0.85,
      "evidence": "therapeutic target in neurological disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "cAMP signaling pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.95,
      "evidence": "cAMP signaling pathway",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "G-protein coupled receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.9,
      "evidence": "G-protein coupled receptor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "Adenyl cyclase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.9,
      "evidence": "Adenyl cyclase",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE-4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.9,
      "evidence": "PDE-4",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "Other Neurological Disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.85,
      "evidence": "Other Neurological Disorders",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "Stroke",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.9,
      "evidence": "Stroke",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "Parkinson's Disease",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.9,
      "evidence": "Parkinson's Disease",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "Alzheimer's Disease",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.9,
      "evidence": "Alzheimer's Disease",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "NF\u03baB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.8,
      "evidence": "NF\u03baB",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "Amyloid beta",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.8,
      "evidence": "Amyloid beta",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "NFT",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.75,
      "evidence": "NFT (Neurofibrillary Tangles)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "cAMP levels decrease",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.85,
      "evidence": "cAMP levels are shown to decrease",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "cAMP levels increase",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "confidence": 0.85,
      "evidence": "cAMP levels are shown to increase",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "Phosphodiesterases",
      "attributes": {
        "target_type": "enzyme family"
      },
      "source_chunk_ids": [
        "79ab3379a4ebc8f097a9e63f7d9a466a"
      ],
      "confidence": 0.95,
      "evidence": "Phosphodiesterases (PDE) are a diverse family of enzymes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme isoform"
      },
      "source_chunk_ids": [
        "79ab3379a4ebc8f097a9e63f7d9a466a"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 (PDE4) is the major isoform",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "cyclic nucleotide"
      },
      "source_chunk_ids": [
        "79ab3379a4ebc8f097a9e63f7d9a466a"
      ],
      "confidence": 0.85,
      "evidence": "cyclic adenosine monophosphate (cAMP)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cGMP",
      "attributes": {
        "target_type": "cyclic nucleotide"
      },
      "source_chunk_ids": [
        "79ab3379a4ebc8f097a9e63f7d9a466a"
      ],
      "confidence": 0.85,
      "evidence": "cyclic guanosine monophosphate (cGMP)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "chronic obstruction pulmonary disease (COPD)",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "chronic obstruction pulmonary disease (COPD)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "asthma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "asthma",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "psoriasis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "psoriasis",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "rheumatoid arthritis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "rheumatoid arthritis",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "neurological disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Product",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Product",
      "name": "apremilast",
      "attributes": {},
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "apremilast",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Product",
      "name": "crisaborole",
      "attributes": {},
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "crisaborole",
      "verified": true
    },
    {
      "id": "E10",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "unbearable"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.85,
      "evidence": "unbearable nausea",
      "verified": true
    },
    {
      "id": "E11",
      "type": "AdverseEvent",
      "name": "vomiting",
      "attributes": {
        "severity": "unbearable"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.85,
      "evidence": "vomiting",
      "verified": true
    },
    {
      "id": "E12",
      "type": "AdverseEvent",
      "name": "dose intolerance",
      "attributes": {},
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.8,
      "evidence": "dose intolerance",
      "verified": true
    },
    {
      "id": "E13",
      "type": "AdverseEvent",
      "name": "diarrhoea",
      "attributes": {},
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.85,
      "evidence": "diarrhoea",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "Alzheimer's disease (AD)",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "Alzheimer's disease (AD)",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "Parkinson's disease (PD)",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "Parkinson's disease (PD)",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Condition",
      "name": "Huntington's disease (HD)",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "Huntington's disease (HD)",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Condition",
      "name": "multiple sclerosis (MS)",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.95,
      "evidence": "multiple sclerosis (MS)",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Condition",
      "name": "sleep disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.9,
      "evidence": "sleep disorders",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.8,
      "evidence": "This review",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Study",
      "name": "on-going clinical trials on PDE4 inhibitors",
      "attributes": {
        "design": "clinical trials"
      },
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "confidence": 0.75,
      "evidence": "on-going clinical trials on PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "Phosphodiesterases",
      "attributes": {
        "target_type": "enzyme super-family"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.95,
      "evidence": "Phosphodiesterases (PDEs) are a super-family of enzymes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 enzyme is predominant amongst the 11 PDE super-family enzymes",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme isoform"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.8,
      "evidence": "PDE4A, PDE4B, PDE4C and PDE4D",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme isoform"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.8,
      "evidence": "PDE4A, PDE4B, PDE4C and PDE4D",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme isoform"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.8,
      "evidence": "PDE4A, PDE4B, PDE4C and PDE4D",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme isoform"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.8,
      "evidence": "PDE4A, PDE4B, PDE4C and PDE4D",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "myomegalin",
      "attributes": {
        "target_type": "structural protein"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.85,
      "evidence": "PDEs interact with myomegalin (a structural protein)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.9,
      "evidence": "inflammatory diseases like chronic obstructive pulmonary disease (COPD)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "asthma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.9,
      "evidence": "inflammatory diseases like ... asthma",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "cancer",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.85,
      "evidence": "overexpression of PDE4 is recorded in cancer",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "retinal degeneration",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.85,
      "evidence": "overexpression of PDE4 is recorded in ... retinal degeneration",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "acrodysostosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.85,
      "evidence": "overexpression of PDE4 is recorded in ... acrodysostosis",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "Alzheimer's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.85,
      "evidence": "overexpression of PDE4 is recorded in ... Alzheimer's disease (AD)",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "stroke",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.85,
      "evidence": "overexpression of PDE4 is recorded in ... stroke",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "hydrolyse cyclic nucleotides",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.8,
      "evidence": "PDE enzymes hydrolyse cyclic nucleotides \u2013 cAMP and cGMP",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "plays important roles in cellular functions",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.75,
      "evidence": "plays important roles in cellular functions",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "crucial role in cardiac contractility",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.7,
      "evidence": "play crucial role in cardiac contractility",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "involved in cytoskeletal assembly and disassembly",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.7,
      "evidence": "involved in cytoskeletal assembly and disassembly",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "deleterious effects of increased expression",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "confidence": 0.75,
      "evidence": "deleterious effects of increased expression of PDE4",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4 enzymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 enzymes hydrolyse cAMP",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "increase cAMP levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.9,
      "evidence": "PDE4Is increase cAMP levels",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.85,
      "evidence": "PDE4B inhibitor",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "Roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.9,
      "evidence": "Roflumilast",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "Apremilast",
      "attributes": {},
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.9,
      "evidence": "Apremilast",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.95,
      "evidence": "for COPD",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "psoriasis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.95,
      "evidence": "psoriasis treatment",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "suppress TNF\u03b1, IL-17, IL-23 expression",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.85,
      "evidence": "suppress TNF\u03b1, IL-17, IL-23 expression",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "up-regulate IL-10",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.85,
      "evidence": "up-regulate the anti-inflammatory gene IL-10",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "Parkinson's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.9,
      "evidence": "Parkinson's disease (PD)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "Huntington's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.9,
      "evidence": "Huntington's disease (HD)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "AD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.8,
      "evidence": "AD",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.9,
      "evidence": "depression",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "multiple sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.9,
      "evidence": "multiple sclerosis (MS)",
      "verified": true
    },
    {
      "id": "E15",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "dose limiting"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.85,
      "evidence": "nausea",
      "verified": true
    },
    {
      "id": "E16",
      "type": "AdverseEvent",
      "name": "vomiting",
      "attributes": {
        "severity": "dose limiting"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.85,
      "evidence": "vomiting",
      "verified": true
    },
    {
      "id": "E17",
      "type": "AdverseEvent",
      "name": "gastric acidity",
      "attributes": {
        "severity": "dose limiting"
      },
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "confidence": 0.85,
      "evidence": "gastric acidity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "CompoundClass",
      "name": "PDE5 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.9,
      "evidence": "PDE5 inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "CompoundClass",
      "name": "PDE7 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.9,
      "evidence": "PDE7 inhibitors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "AdverseEvent",
      "name": "non-arteritic anterior ischemic optic neuropathy",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "non-arteritic anterior ischemic optic neuropathy",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "hearing loss",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "hearing loss",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "tachycardia",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.8,
      "evidence": "tachycardia",
      "verified": true
    },
    {
      "id": "E6",
      "type": "AdverseEvent",
      "name": "reduced peripheral blood pressure",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.8,
      "evidence": "reduced peripheral blood pressure",
      "verified": true
    },
    {
      "id": "E7",
      "type": "CompoundClass",
      "name": "PDE4 allosteric modulators",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 allosteric modulators",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "GSK256066",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "GSK256066",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "GEBR-7b",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "GEBR-7b",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "D159687",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "D159687",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "D159797",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "D159797",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "TAK-648",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "TAK-648",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "improved blood brain barrier penetrability",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.8,
      "evidence": "improved blood brain barrier penetrability",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "high potency",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.75,
      "evidence": "high potency",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "low side effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.75,
      "evidence": "low side effects",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Condition",
      "name": "inflammatory diseases",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "inflammatory diseases",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Condition",
      "name": "diabetes",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "diabetes",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Condition",
      "name": "autoimmune disorders",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.85,
      "evidence": "autoimmune disorders",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Condition",
      "name": "neurological disorders",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.9,
      "evidence": "PDE4",
      "verified": true
    },
    {
      "id": "E21",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE enzymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "560a5b48498999c10e5774df2bbd6527"
      ],
      "confidence": 0.9,
      "evidence": "PDE enzymes possess conserved catalytic domain",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "560a5b48498999c10e5774df2bbd6527"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 is highly specific for cAMP",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.95,
      "evidence": "PDE4s are divided into subgroups",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.9,
      "evidence": "catalytic domain of PDE4B",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4D2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.9,
      "evidence": "random loop of residues 422\u2013434 in PDE4D2",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.85,
      "evidence": "one Zn2+ ion per PDE4A monomer",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE7",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.8,
      "evidence": "two Zn2+ ions for PDE7 (Vibrio fischeri)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "PDE5",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.8,
      "evidence": "three Zn2+ ions for PDE5",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "catalytic pocket",
      "attributes": {
        "target_type": "structural site"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.85,
      "evidence": "catalytic pocket and has a volume",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "metal binding sites",
      "attributes": {
        "target_type": "structural site"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.8,
      "evidence": "two metal binding sites",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.75,
      "evidence": "accommodate a molecule such as cAMP",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "AMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.75,
      "evidence": "PDE4\u2013adenosine monophosphate (AMP) structure",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "Zn2+",
      "attributes": {
        "target_type": "metal ion"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.9,
      "evidence": "Zn2+ binding consensus motifs",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "Mg2+",
      "attributes": {
        "target_type": "metal ion"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.8,
      "evidence": "Mg2+ needed for enzymatic activity",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "Co2+",
      "attributes": {
        "target_type": "metal ion"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.8,
      "evidence": "Co2+ needed for enzymatic activity",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "Mn2+",
      "attributes": {
        "target_type": "metal ion"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.8,
      "evidence": "Mn2+ needed for enzymatic activity",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "Ni2+",
      "attributes": {
        "target_type": "metal ion"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.8,
      "evidence": "Ni2+ needed for enzymatic activity",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "PKA",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.85,
      "evidence": "UCR1 phosphorylates protein kinase A (PKA)",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Target",
      "name": "phosphoinositide-3-kinase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.85,
      "evidence": "phosphoinositide-3-kinase results in inhibition",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Target",
      "name": "ERK",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.85,
      "evidence": "extracellular signal-regulated kinase (ERK)",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "inhibition of PDE4",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.9,
      "evidence": "results in inhibition of PDE4",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Effect",
      "name": "enzyme activation",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.8,
      "evidence": "UCR1 phosphorylates PKA dependent enzyme activation",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Effect",
      "name": "stabilize protein structure",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "confidence": 0.85,
      "evidence": "metal ions stabilize the protein structure",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.95,
      "evidence": "Expression of PDE4 is ubiquitous",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "AD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders like AD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "PD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders like ... PD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "MS",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders like ... MS",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "ALS",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders like ... ALS",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "glioma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders like ... glioma",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "stroke",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders like ... stroke",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.9,
      "evidence": "neurological disorders like ... depression",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.85,
      "evidence": "expression of PDE4A, B, D was found to be high",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.85,
      "evidence": "expression of PDE4A, B, D was found to be high",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.85,
      "evidence": "PDE4C was found to be high",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "confidence": 0.85,
      "evidence": "expression of PDE4A, B, D was found to be high",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 hydrolyses cAMP",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "signaling molecule"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.85,
      "evidence": "cAMP activates protein kinase A",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "protein kinase A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.8,
      "evidence": "cAMP activates protein kinase A",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "BDNF",
      "attributes": {
        "target_type": "neurotrophic factor"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.8,
      "evidence": "brain derived neurotropic factors (BDNF)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "CREB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.9,
      "evidence": "cAMP Response Element-Binding Protein (CREB)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "CBP",
      "attributes": {
        "target_type": "coactivator"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.8,
      "evidence": "CREB binding protein (CBP)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "long term potentiation (LTP)",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ea3aa23e",
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.85,
      "evidence": "long term potentiation (LTP)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.85,
      "evidence": "synaptic plasticity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "cognitive functions",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.8,
      "evidence": "pivotal role in cognitive functions",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "CREB phosphorylation",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.8,
      "evidence": "CREB phosphorylation",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "cognitive dysfunction",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.85,
      "evidence": "Mutations in CREB causes cognitive dysfunction",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.85,
      "evidence": "Mutations in CREB causes mood disorders",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "mental retardation",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.8,
      "evidence": "patients with mental retardation",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "memory dysfunction",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "confidence": 0.8,
      "evidence": "mouse models also suffer from memory dysfunction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram is reported",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "improves long-term memory",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.85,
      "evidence": "improve long-term memory",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "CREB signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.9,
      "evidence": "CREB signalling",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "CBP mutations",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.8,
      "evidence": "CBP mutations",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "promotes neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.85,
      "evidence": "promotes neurogenesis",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "hippocampal region",
      "attributes": {
        "target_type": "region"
      },
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.8,
      "evidence": "hippocampal region",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "enhances neuronal survival",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.85,
      "evidence": "enhances the neuronal survival",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "cAMP/CREB signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.9,
      "evidence": "cAMP/CREB signalling",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "imipramine",
      "attributes": {},
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "confidence": 0.95,
      "evidence": "imipramine",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "CREB",
      "attributes": {},
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.9,
      "evidence": "level of CREB",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "BDNF",
      "attributes": {},
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.9,
      "evidence": "level of BDNF",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cAMP/CREB/BDNF signalling",
      "attributes": {},
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.85,
      "evidence": "cAMP/CREB/BDNF signalling",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "antidepressant-like effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.8,
      "evidence": "exert antidepressant-like effects",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "RACK1",
      "attributes": {},
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.9,
      "evidence": "receptor for activated C kinase 1 (RACK1)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "GNB2L1",
      "attributes": {},
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.85,
      "evidence": "guanine nucleotide-binding protein subunit beta-2-like 1 (GNB2L1)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "cAMP/PKA pathway",
      "attributes": {},
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.85,
      "evidence": "cAMP/PKA pathway",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE4D5",
      "attributes": {},
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.8,
      "evidence": "PDE4D5",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "NMDA-receptors",
      "attributes": {},
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.8,
      "evidence": "NMDA-receptors",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "memory functions",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "confidence": 0.75,
      "evidence": "involvement in memory functions",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "nitric oxide synthase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.9,
      "evidence": "Ca^{2+}-regulated enzyme nitric oxide synthase (NOS)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "soluble guanylyl cyclase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.9,
      "evidence": "soluble guanylyl cyclase (sGC)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cGMP dependent protein kinase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.85,
      "evidence": "cGMP dependent protein kinase (PKG)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase enzymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.8,
      "evidence": "Phosphodiesterase enzymes impede the signal transduction",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "NMDA receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.9,
      "evidence": "N-methyl-D-aspartate-type glutamate (NMDA) receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "PDE2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.8,
      "evidence": "specific PDE2 inhibitor (Bay 60-7550)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PDE5",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.85,
      "evidence": "PDE5 inhibitors increase NO/cGMP/PKG signalling",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.8,
      "evidence": "Inhibition of PDE4 with rolipram",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "enhanced memory",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.85,
      "evidence": "enhance memory",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "improved memory consolidation",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.8,
      "evidence": "improve memory consolidation",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "improved cognitive function",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.8,
      "evidence": "improve cognitive function",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "anxiolytic effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.85,
      "evidence": "elicited anxiolytic effects",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "memory deficits",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.8,
      "evidence": "MK801-induced memory deficits",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "anxiety",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.75,
      "evidence": "anxiolytic effects",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "preclinical studies on PDE5 inhibitors",
      "attributes": {
        "design": "preclinical studies"
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.8,
      "evidence": "Preclinical studies have shown that PDE5 inhibitors",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "preclinical evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "confidence": 0.75,
      "evidence": "Preclinical studies have shown",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE enzymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "052100099747fa98b3d9e363d741640b"
      ],
      "confidence": 0.9,
      "evidence": "PDE enzymes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NO/cGMP/PKG pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "052100099747fa98b3d9e363d741640b"
      ],
      "confidence": 0.85,
      "evidence": "NO/cGMP/PKG pathway",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "beneficial effects in brain disorders",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "052100099747fa98b3d9e363d741640b"
      ],
      "confidence": 0.8,
      "evidence": "elicits beneficial effects in brain disorders",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "brain disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "052100099747fa98b3d9e363d741640b"
      ],
      "confidence": 0.75,
      "evidence": "brain disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "MAPK pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.9,
      "evidence": "mitogen-activated protein kinase (MAPK) pathway",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "ERK signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.9,
      "evidence": "ERK signalling",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PKA",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.85,
      "evidence": "cyclic AMP/protein kinase A (PKA)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.9,
      "evidence": "PDE4",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "CREB",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.9,
      "evidence": "CREB",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "NMDA receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.9,
      "evidence": "NMDA receptors",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.85,
      "evidence": "synaptic plasticity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "memory",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.85,
      "evidence": "memory",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "LTP",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.8,
      "evidence": "LTP",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "cognitive deficits",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.8,
      "evidence": "cognitive deficits",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "memory deficits",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.8,
      "evidence": "memory deficits",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "CREB phosphorylation",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "confidence": 0.75,
      "evidence": "CREB phosphorylation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "cAMP/PKA/CREB signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "confidence": 0.9,
      "evidence": "cAMP/ PKA/CREB signalling",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "BDNF",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "confidence": 0.95,
      "evidence": "transcription of BDNF",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "hippocampal LTP",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "confidence": 0.85,
      "evidence": "hippocampal LTP",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "neuroplasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "confidence": 0.8,
      "evidence": "neuroplasticity",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "confidence": 0.8,
      "evidence": "accelerates neurogenesis",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "confidence": 0.8,
      "evidence": "synaptic plasticity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 hydrolyses cAMP",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A5",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A5 is shown to reduce LTP",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "PDE4A knockout mice",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cAMP/PKA/CREB/BDNF signal",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.8,
      "evidence": "cAMP/PKA/CREB/BDNF signal",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.9,
      "evidence": "nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "AMPA-glutamate receptor1 (GluR1)",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "AMPA-glutamate receptor1(GluR1)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PSD-95",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "postsynaptic density protein 95 (PSD-95)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "cAMP/PKA/MAPK/CREB pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.8,
      "evidence": "cAMP/PKA/MAPK/CREB pathway",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "inhibit neuroplasticity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "inhibit neuroplasticity",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "reduce LTP and dendritic spine number",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.9,
      "evidence": "reduce LTP and dendritic spine number",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "neuronal cell proliferation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "Neuronal cell proliferation",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "improve hippocampal LTP and dendritic spines density",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.9,
      "evidence": "improve hippocampal LTP and dendritic spines density",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "enhance neural progenitor cell production",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "enhance the neural progenitor cell production",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "inhibition of proinflammatory cytokines release",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.8,
      "evidence": "Inhibition of proinflammatory cytokines release",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "reduce IL-1\u03b2, TNF-\u03b1, NF-\u03baB levels",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "reduce the levels of interleukin-1-beta (IL-1\u03b2), TNF-\u03b1, NF-\u03baB",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "increase pCREB and BDNF expression",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "increase the expression of pCREB and BDNF",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "activation of PKA, BDNF and CREB phosphorylation",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "activation of PKA, BDNF and CREB phosphorylation",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "prevent deficits in synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.9,
      "evidence": "prevents primary blast-induced deficits in synaptic plasticity",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "increase AMPA-GluR1 and PSD-95 expression",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "increases the expression of AMPA-glutamate receptor1(GluR1) and PSD-95",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Effect",
      "name": "facilitate synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.85,
      "evidence": "facilitates synaptic plasticity",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram is shown enhance",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Compound",
      "name": "FFPM",
      "attributes": {},
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.9,
      "evidence": "FFPM, a PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Compound",
      "name": "Roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "confidence": 0.95,
      "evidence": "Roflumilast prevents",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase have a pivotal role",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "confidence": 0.85,
      "evidence": "inhibition of PDE4 appear as potential target",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "cognitive decline",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "confidence": 0.8,
      "evidence": "corroborated for cognitive decline",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "AD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "confidence": 0.8,
      "evidence": "progression of AD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "PD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "confidence": 0.8,
      "evidence": "PD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "psychosis",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "confidence": 0.8,
      "evidence": "psychosis",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "confidence": 0.8,
      "evidence": "depression",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "neurological disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "confidence": 0.75,
      "evidence": "treatment of neurological disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "confidence": 0.95,
      "evidence": "PDE4D by D159687 and D159797",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "D159687",
      "attributes": {},
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "confidence": 0.9,
      "evidence": "D159687 and D159797",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "D159797",
      "attributes": {},
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "confidence": 0.9,
      "evidence": "D159687 and D159797",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "improved retrieval process",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "confidence": 0.85,
      "evidence": "improve the retrieval process",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 is linked directly or indirectly",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "Alzheimer's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "confidence": 0.9,
      "evidence": "AD treatment",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Study (124)",
      "attributes": {
        "reference": "124"
      },
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "confidence": 0.8,
      "evidence": "(124)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "confidence": 0.75,
      "evidence": "female Cynomolgus Monkeys",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "Parkinson's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.95,
      "evidence": "Parkinson's disease is a progressive neurodegenerative disease",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors appear to be promising drugs",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "FCPR16",
      "attributes": {},
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.95,
      "evidence": "FCPR16, a PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cAMP/PKA/CREB pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.85,
      "evidence": "mediated by cAMP/PKA/CREB and Epac/Akt signalling pathways",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "AMPK pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.85,
      "evidence": "via 5' AMP-activated protein kinase (AMPK) pathway",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "XT-44",
      "attributes": {},
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.95,
      "evidence": "XT-44 (1-n-butyl-3-n-propylxanthine), a PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram increases tyrosine hydroxylase (TH) phosphorylation",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "double-blind trial",
      "attributes": {
        "design": "double-blind trial"
      },
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.8,
      "evidence": "in a double-blind trial",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.75,
      "evidence": "double-blind trial",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "improves dopamine levels",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.85,
      "evidence": "improves the level of dopamine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "alleviates Parkinsonism severity",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "confidence": 0.85,
      "evidence": "alleviates the severity of Parkinsonism",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.95,
      "evidence": "ibudilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "protect astrocytes",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.85,
      "evidence": "protect the astrocytes",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "inhibit cytochrome c release",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.8,
      "evidence": "inhibiting the release of cytochrome c",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "inhibit caspase-3 activation",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.8,
      "evidence": "caspase-3 activation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "inhibit nuclear condensation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.8,
      "evidence": "nuclear condensation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "increase cGMP levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.85,
      "evidence": "increase in cGMP levels",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.9,
      "evidence": "PDE inhibition",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "Parkinson's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.9,
      "evidence": "PD",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "in vitro and animal model",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.8,
      "evidence": "rat model",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Study reference 142",
      "attributes": {
        "year": null,
        "doi": null
      },
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "confidence": 0.7,
      "evidence": "(142)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "multiple sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.95,
      "evidence": "Multiple sclerosis (MS) is an autoimmune disease",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.9,
      "evidence": "cAMP is recognized as a significant player",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.9,
      "evidence": "Increasing cAMP levels through PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decreased cAMP levels",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.8,
      "evidence": "Decreased levels of cAMP in the cerebrospinal fluid",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "demyelination",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.85,
      "evidence": "demyelination in MS patients",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "inflammation reduction",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.75,
      "evidence": "cAMP analogues are also reported to reduce inflammation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "myelin repair",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.8,
      "evidence": "performs myelin repair in MS",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "immune response suppression",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.8,
      "evidence": "PDE4 inhibition suppresses the immune response",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "remyelination increase",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.8,
      "evidence": "increases remyelination",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "Dibutyryl cyclic AMP",
      "attributes": {},
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "confidence": 0.9,
      "evidence": "cAMP analogue, Dibutyryl cyclic AMP",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram decreases TNF-\u03b1 levels",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.9,
      "evidence": "TNF-\u03b1 levels",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "MAPK phosphatase-1",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.85,
      "evidence": "MAPK phosphatase-1",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.9,
      "evidence": "inhibiting NF-\u03baB complexes",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "inflammation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.9,
      "evidence": "reduced inflammation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "demyelination",
      "attributes": {
        "condition_type": "pathology"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.85,
      "evidence": "demyelination",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "clinical signs of EAE",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.8,
      "evidence": "delayed onset of clinical signs",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "multiple sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.75,
      "evidence": "EAE rodent model of MS",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "decreased TNF-\u03b1 levels",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.85,
      "evidence": "decreases TNF-\u03b1 levels",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "increased MAPK phosphatase-1 expression",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.8,
      "evidence": "increasing the expression of MAPK phosphatase-1",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "inhibited NF-\u03baB complexes",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.8,
      "evidence": "inhibiting NF-\u03baB complexes",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "reduced inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.85,
      "evidence": "reduced inflammation",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "reduced demyelination",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.8,
      "evidence": "demyelination",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "delayed onset of clinical signs",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.8,
      "evidence": "delayed onset of clinical signs",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "confidence": 0.9,
      "evidence": "Ibudilast is found",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "BBB022",
      "attributes": {},
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.85,
      "evidence": "BBB022, a PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.85,
      "evidence": "in combination with rolipram",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "EAE",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.9,
      "evidence": "decreases the severity of EAE",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "MS",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.9,
      "evidence": "EAE induced MS",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decreases severity of EAE",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.8,
      "evidence": "decreases the severity of EAE",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "stabilizes blood brain barrier",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.8,
      "evidence": "stabilizes the blood brain barrier",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "clinical trials investigating PDE4 inhibitors in MS",
      "attributes": {
        "design": "clinical trials",
        "year": "underway"
      },
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.75,
      "evidence": "Clinical trials are underway",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "preclinical and clinical evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "confidence": 0.7,
      "evidence": "Preclinical and clinical evidence",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.95,
      "evidence": "Schizophrenia is a serious psychiatric illness",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.9,
      "evidence": "possible role of PDE4 in schizophrenia",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.85,
      "evidence": "disrupted in PDE4B gene cause schizophrenia",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "DISC1",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.8,
      "evidence": "PDE4B associates with disrupted in schizophrenia 1 (DISC1)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Clapcote et al., (2007)",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.9,
      "evidence": "Clapcote et al., (2007) found",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.8,
      "evidence": "Animal studies have given ample evidences",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram is shown to antagonize",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.95,
      "evidence": "Roflumilast improves verbal learning",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "antipsychotic-like properties",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors like rolipram and roflumilast possess antipsychotic-like properties",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "improved verbal learning",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.8,
      "evidence": "Roflumilast improves verbal learning",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "reduced hyperactivity",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.75,
      "evidence": "reduce methamphetamine-induced hyper-locomotion",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "reversed sensory processing deficits",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "confidence": 0.7,
      "evidence": "reverses amphetamine-disrupted auditory sensory processing",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.95,
      "evidence": "Depression, the most common mental illness",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "cAMP signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.85,
      "evidence": "dysfunction of cAMP signalling in depressive patients",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "\u03b21-adrenergic receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.9,
      "evidence": "\u03b21 and \u03b22- adrenergic receptors produce anti-depressant like effects",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "\u03b22-adrenergic receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.9,
      "evidence": "\u03b21 and \u03b22- adrenergic receptors produce anti-depressant like effects",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "adenylyl cyclase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.8,
      "evidence": "increase the formation of cAMP through adenylyl cyclase stimulation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 inhibition produced an \u201cadditive\u201d anti-depressant effect",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PDE4D8",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.75,
      "evidence": "\u03b21- adrenergic receptor preferentially associates with PDE4D8",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE4D5",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.75,
      "evidence": "\u03b22/\u03b2-arrestin complex has higher affinity to PDE4D5",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Zhang et al., 2005",
      "attributes": {
        "year": 2005
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.9,
      "evidence": "Zhang et al., (2005) demonstrated that PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.8,
      "evidence": "administered along with dobutamine, \u03b21 agonist in rats",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "dobutamine",
      "attributes": {},
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.85,
      "evidence": "dobutamine, \u03b21 agonist",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "clenbuterol",
      "attributes": {},
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.85,
      "evidence": "clenbuterol, \u03b22- agonist",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "anti-depressant effect",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.9,
      "evidence": "anti-depressant effect when administered along with dobutamine",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "synergistic effect",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.8,
      "evidence": "synergistic was observed when administered clenbuterol",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "serotonergic system",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.75,
      "evidence": "PDE association with serotonergic system in brain",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.85,
      "evidence": "rolipram, produced showed significant behavioural improvement",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Condition",
      "name": "major depressive disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.9,
      "evidence": "major depressive disorder patients",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "behavioural improvement",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.85,
      "evidence": "significant behavioural improvement in major depressive disorder patients",
      "verified": true
    },
    {
      "id": "E19",
      "type": "AdverseEvent",
      "name": "cardiovascular risks",
      "attributes": {
        "severity": "unknown"
      },
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "confidence": 0.7,
      "evidence": "involvement of cardiovascular risks hinders clinical investigation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.95,
      "evidence": "Upregulation of PDE4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.9,
      "evidence": "depressive rat cortex region",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cAMP-PKA-CREB signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.85,
      "evidence": "decreased cAMP-PKA-CREB",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cAMP-ERK1/2-CREB signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.85,
      "evidence": "cAMP-ERK1/2-CREB signalling",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.9,
      "evidence": "decrease in cAMP levels",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Fujita et al (2017)",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.8,
      "evidence": "Fujita et al (2017)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "clinical evidence",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.75,
      "evidence": "decrease in cAMP levels in living depressive patients",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increased cAMP levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.85,
      "evidence": "Inhibition of PDE4 increases the level of cAMP",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "increased pCREB",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.8,
      "evidence": "increases the level of cAMP, pCREB",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "promoted hippocampal neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.8,
      "evidence": "promote hippocampal neurogenesis",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "antidepressant-like effect",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.85,
      "evidence": "antidepressant-like effect",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "clinical trials",
      "attributes": {
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.7,
      "evidence": "Clinical trials are underway",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "clinical trial evidence",
      "attributes": {
        "evidence_level": 4,
        "verification_needed": true
      },
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "confidence": 0.65,
      "evidence": "Clinical trials are underway",
      "verified": false
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "Huntington's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a0f5122054e92f36655191105a73ed2c"
      ],
      "confidence": 0.95,
      "evidence": "Huntington's disease is a neurological disorder",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "Huntingtin protein",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "a0f5122054e92f36655191105a73ed2c"
      ],
      "confidence": 0.9,
      "evidence": "Huntingtin (Htt) protein",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "increased cellular toxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a0f5122054e92f36655191105a73ed2c"
      ],
      "confidence": 0.85,
      "evidence": "causes increased cellular toxicity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "inclusion bodies formation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a0f5122054e92f36655191105a73ed2c"
      ],
      "confidence": 0.8,
      "evidence": "generates inclusion bodies (IBs)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "Huntington's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.9,
      "evidence": "development of HD",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.85,
      "evidence": "overexpression of PDE4",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.95,
      "evidence": "rolipram is shown",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "CREB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.8,
      "evidence": "phosphorylation of CREB",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "BDNF",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.8,
      "evidence": "increase the phosphorylation of BDNF",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "increased phosphorylation of CREB and BDNF",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.75,
      "evidence": "increase the phosphorylation of CREB and BDNF",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "improved clinical signs in rodent model",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.7,
      "evidence": "improves the clinical signs in rodent model",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduced cortical and striatal neuronal degeneration",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.7,
      "evidence": "reduce cortical and striatal neuronal degeneration",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "GlaxoSmithKline clinical trial Phase 1",
      "attributes": {
        "design": "clinical trial",
        "phase": "Phase 1"
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.85,
      "evidence": "GlaxoSmithKline is performing a clinical trial",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "confidence": 0.8,
      "evidence": "clinical trial",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "stroke",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.95,
      "evidence": "Stroke is a neurodegenerative disease",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "ischemic stroke",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.9,
      "evidence": "An ischemic stroke occurs when blood to brain is blocked",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "haemorrhagic stroke",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.9,
      "evidence": "haemorrhagic stroke occurs when an artery ruptures in brain",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.9,
      "evidence": "Decrease in cAMP leads to activation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram restores endothelial function",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "decreased stroke risk",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.85,
      "evidence": "decrease in stroke risk with PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduced infarct size",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.85,
      "evidence": "reduces the infarct size in hippocampal region",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "restored endothelial function",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.85,
      "evidence": "Rolipram restores endothelial function",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "increased hippocampal neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.85,
      "evidence": "Rolipram increases hippocampal neurogenesis",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "decreased ischemic injury",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.85,
      "evidence": "decreases ischemic injury in neuronal cultures",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "prevented blood brain barrier disruption",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 inhibition prevents blood brain barrier disruption",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "reduced proinflammatory cytokines",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.85,
      "evidence": "reduces the secretion of proinflammatory cytokines",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "inhibited neuronal apoptosis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.85,
      "evidence": "inhibits neuronal apoptosis in rat model",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Gretarsdottir et al. (2003)",
      "attributes": {
        "year": 2003
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.9,
      "evidence": "Gretarsdottir et al. (2003) reported",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "confidence": 0.8,
      "evidence": "in rat model of cerebral stroke",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDEs",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "confidence": 0.9,
      "evidence": "PDEs are implicated",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "tumours",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "confidence": 0.85,
      "evidence": "development of various tumours",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "confidence": 0.9,
      "evidence": "role of cAMP on brain tumours",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "brain tumours",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "confidence": 0.85,
      "evidence": "role of cAMP on brain tumours",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "glioma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "confidence": 0.9,
      "evidence": "role of cAMP on the development of glioma",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "confidence": 0.8,
      "evidence": "in vitro and in vivo models",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "in vivo",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "confidence": 0.8,
      "evidence": "in vitro and in vivo models",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "traumatic brain injury",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.95,
      "evidence": "Traumatic brain injury (TBI)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "cognitive deficits",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.9,
      "evidence": "cognitive deficits",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.9,
      "evidence": "expression of PDE4",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4B2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.85,
      "evidence": "PDE4B2 levels increase",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4D2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D2 is also highly expressed",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "cAMP-PKA pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.8,
      "evidence": "dysfunction of the cAMP-PKA pathway",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.85,
      "evidence": "decrease in cAMP levels",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "release of proinflammatory mediators",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.8,
      "evidence": "triggers the release of proinflammatory mediators",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "affects LTP in the hippocampus",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.75,
      "evidence": "affects LTP in the hippocampus",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "cognitive decline",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.85,
      "evidence": "leads to cognitive decline",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram has been found",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "reduces expression of inflammatory mediators",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.85,
      "evidence": "reduce the expression of inflammatory mediators",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.8,
      "evidence": "TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.8,
      "evidence": "IL-1\u03b2",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "improves cognitive function",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.85,
      "evidence": "improves cognitive function",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "prevents neuronal loss",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "confidence": 0.8,
      "evidence": "prevent neuronal loss",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 is a potential target",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "TBI",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "confidence": 0.95,
      "evidence": "TBI animals, management of TBI",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "confidence": 0.95,
      "evidence": "rolipram modulates PDE4 isoforms",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduces deposition of beta-amyloid precursor protein",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "confidence": 0.85,
      "evidence": "reduces the deposition of the beta-amyloid precursor protein",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "modulates PDE4 isoforms",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "confidence": 0.9,
      "evidence": "rolipram modulates PDE4 isoforms",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "manages TBI symptoms",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "confidence": 0.8,
      "evidence": "can effectively manage TBI symptoms",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "vascular dementia",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.95,
      "evidence": "Vascular dementia (VD)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.9,
      "evidence": "Inhibition of PDE4",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "increased cAMP level",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.85,
      "evidence": "increase in cAMP level",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "improved cerebral blood flow",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.8,
      "evidence": "improves blood flow to the brain",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "improved memory functions",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.75,
      "evidence": "improves memory functions",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.9,
      "evidence": "Rolipram is shown",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.9,
      "evidence": "administration of roflumilast",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "betulinic acid",
      "attributes": {},
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.9,
      "evidence": "Betulinic acid",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "alpha-mangostin",
      "attributes": {},
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.9,
      "evidence": "alpha-mangostin",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Liang et al. (2020)",
      "attributes": {
        "year": 2020
      },
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.85,
      "evidence": "Liang et al. (2020) reported",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.8,
      "evidence": "in beagle dogs",
      "verified": true
    },
    {
      "id": "E12",
      "type": "AdverseEvent",
      "name": "emesis",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "confidence": 0.7,
      "evidence": "does not cause emesis behaviour",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "AD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "confidence": 0.8,
      "evidence": "neurological diseases like AD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "PD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "confidence": 0.8,
      "evidence": "neurological diseases like PD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "MS",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "confidence": 0.8,
      "evidence": "neurological diseases like MS",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "HD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "confidence": 0.8,
      "evidence": "neurological diseases like HD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "stroke",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "confidence": 0.8,
      "evidence": "neurological diseases like stroke",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "confidence": 0.9,
      "evidence": "neurological diseases like depression",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "clinical trials",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "confidence": 0.85,
      "evidence": "Clinical trials conducted so far",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "secondary messenger"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.9,
      "evidence": "intracellular secondary messengers cAMP",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "cGMP",
      "attributes": {
        "target_type": "secondary messenger"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.9,
      "evidence": "intracellular secondary messengers cGMP",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram, a cAMP specific PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "clinical trial 1992",
      "attributes": {
        "year": 1992,
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.85,
      "evidence": "In 1992, a clinical trial with rolipram",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.8,
      "evidence": "clinical trial with rolipram",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.9,
      "evidence": "antidepressant activity",
      "verified": true
    },
    {
      "id": "E8",
      "type": "AdverseEvent",
      "name": "emesis",
      "attributes": {
        "severity": "dose dependent"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.85,
      "evidence": "dose dependent side effects like emesis",
      "verified": true
    },
    {
      "id": "E9",
      "type": "AdverseEvent",
      "name": "headache",
      "attributes": {
        "severity": "dose dependent"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.85,
      "evidence": "dose dependent side effects like headache",
      "verified": true
    },
    {
      "id": "E10",
      "type": "AdverseEvent",
      "name": "increased gastric secretion",
      "attributes": {
        "severity": "dose dependent"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.8,
      "evidence": "increased gastric secretion",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.9,
      "evidence": "Inhibition of PDE4D",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "NIH trial 2006",
      "attributes": {
        "year": 2006,
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.85,
      "evidence": "clinical trial was initiated by the National Institute of Health in 2006",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.8,
      "evidence": "clinical trial to re-evaluate",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.9,
      "evidence": "rolipram inhibits both PDE4B and PDE4D",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "neurological disorders",
      "attributes": {
        "condition_type": "disease category"
      },
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "confidence": 0.8,
      "evidence": "neurological disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "cAMP specific PDE4 enzymes",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.9,
      "evidence": "cAMP specific PDE4 enzymes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "airway diseases",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.85,
      "evidence": "airway diseases treatment",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.95,
      "evidence": "roflumilast",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "apremilast",
      "attributes": {},
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.95,
      "evidence": "apremilast",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "RS25344",
      "attributes": {},
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.9,
      "evidence": "RS25344",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "PMNPQ",
      "attributes": {},
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.9,
      "evidence": "PMNPQ",
      "verified": true
    },
    {
      "id": "E8",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.85,
      "evidence": "side effects like nausea",
      "verified": true
    },
    {
      "id": "E9",
      "type": "AdverseEvent",
      "name": "emesis",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.85,
      "evidence": "emesis",
      "verified": true
    },
    {
      "id": "E10",
      "type": "AdverseEvent",
      "name": "gastric hypersecretion",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.8,
      "evidence": "gastric hypersecretion",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "Cilomilast",
      "attributes": {},
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.95,
      "evidence": "Cilomilast",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "PDE4A, B, C, D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "confidence": 0.85,
      "evidence": "all four subtypes (PDE4A, B, C, D)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "confidence": 0.9,
      "evidence": "PDE4D isoform is responsible for emesis",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "emesis",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D isoform is responsible for emesis",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "alpha-2 adrenoceptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "confidence": 0.8,
      "evidence": "PDE4D could potentially modulates the alpha_2-adrenoceptor",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "side effects",
      "attributes": {
        "severity": "unspecified"
      },
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "confidence": 0.75,
      "evidence": "causes emesis and other side effects",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "amplified sympathetic drive",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "confidence": 0.7,
      "evidence": "amplified sympathetic drive",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decrease in sleeping time",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "confidence": 0.7,
      "evidence": "decrease in sleeping time",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "knockout mice study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "confidence": 0.8,
      "evidence": "Studies in knockout mice have shown",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "X-ray crystallography",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "confidence": 0.75,
      "evidence": "X-ray crystallography techniques",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.95,
      "evidence": "PDE4D allosteric modulators",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "D159687",
      "attributes": {},
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.9,
      "evidence": "D159687, a negative allosteric modulator",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "enhances learning and memory",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.85,
      "evidence": "enhances learning and memory in TBI rats",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "TBI",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.8,
      "evidence": "TBI rats",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "emesis",
      "attributes": {},
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.9,
      "evidence": "reduce emesis",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "D159797",
      "attributes": {},
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.9,
      "evidence": "D159797 is a UCR2-directed allosteric modulator",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "improves synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.8,
      "evidence": "improving synaptic plasticity",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increases spine density",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.8,
      "evidence": "increasing the spine density",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "upregulates neurotrophic factors",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.8,
      "evidence": "upregulating the expression of neurotrophic factors",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "neurological disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.85,
      "evidence": "neurological disorders",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 enzyme",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "improved cAMP levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.85,
      "evidence": "improve cAMP levels",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "neuroprotective effects",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.9,
      "evidence": "neuroprotective effects",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "Alzheimer's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.8,
      "evidence": "AD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "Parkinson's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.8,
      "evidence": "PD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "Huntington's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.8,
      "evidence": "HD",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.9,
      "evidence": "depression",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "multiple sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.8,
      "evidence": "MS",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "epilepsy",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.9,
      "evidence": "epilepsy",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.9,
      "evidence": "schizophrenia",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.85,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D",
      "verified": true
    },
    {
      "id": "E13",
      "type": "AdverseEvent",
      "name": "side effects",
      "attributes": {
        "severity": "unspecified"
      },
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "confidence": 0.8,
      "evidence": "side effect",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Smith et al. 2006",
      "attributes": {
        "year": 2006,
        "doi": "https://doi.org/10.1038/sj.bjp.0706495"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.9,
      "evidence": "V. B. Smith, D. Spina, C.P. Page. Phosphodiesterase inhibitors. Br J Pharmacol. (2006)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "review article",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.8,
      "evidence": "Phosphodiesterase inhibitors. Br J Pharmacol. (2006)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.85,
      "evidence": "Phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Lugnier 2006",
      "attributes": {
        "year": 2006,
        "doi": "https://doi.org/10.1016/j.pharmthera.2005.07.003"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.9,
      "evidence": "C. Lugnier, Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther. 109 (3) (2006)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "review article",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.8,
      "evidence": "Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "cyclic nucleotide phosphodiesterase (PDE) superfamily",
      "attributes": {
        "target_type": "enzyme family"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.85,
      "evidence": "Cyclic nucleotide phosphodiesterase (PDE) superfamily",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Uys et al. 2011",
      "attributes": {
        "year": 2011,
        "doi": "https://doi.org/10.1186/1471-2121-12-18"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.9,
      "evidence": "G.M. Uys, A. Ramburan, B. Loos, C.J. Kinnear, L.J. Korkie, J. Mouton, et al. Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C. BMC Cell Biol. (2011)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "basic research",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.8,
      "evidence": "Myomegalin is a novel A-kinase anchoring protein",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "myomegalin",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.85,
      "evidence": "Myomegalin is a novel A-kinase anchoring protein",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "cardiac myosin binding protein C",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.8,
      "evidence": "phosphorylation of cardiac myosin binding protein C",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Verde et al. 2001",
      "attributes": {
        "year": 2001,
        "doi": "https://doi.org/10.1074/jbc.M006546200"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.9,
      "evidence": "I. Verde, G. Pahlke, M. Salanova, G. Zhang, S. Wang, D. Coletti, et al. Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase. J Biol Chem. 276(14) (2001)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "basic research",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.8,
      "evidence": "Myomegalin is a novel protein of the golgi/centrosome",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "cyclic nucleotide phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "confidence": 0.85,
      "evidence": "interacts with a cyclic nucleotide phosphodiesterase",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Journal of Cerebral Blood Flow & Metabolism 22(9) (2002)",
      "attributes": {
        "year": 2002,
        "doi": "10.1097/00004647-200209000-00010"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "Journal of Cerebral Blood Flow & Metabolism 22(9) (2002)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "AdverseEvent",
      "name": "headache",
      "attributes": {
        "population": "healthy subjects"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.95,
      "evidence": "Induces Headache in Healthy Subjects",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "BMC Medicine 11(1) (2013)",
      "attributes": {
        "year": 2013,
        "doi": "10.1186/1741-7015-11-96"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "BMC Medicine. 11(1) (2013)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.95,
      "evidence": "Phosphodiesterase 4-targeted treatments",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "autoimmune diseases",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "autoimmune diseases",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "J Pharmacol Exp Ther 337(1) (2011)",
      "attributes": {
        "year": 2011,
        "doi": "10.1124/jpet.110.173690"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "J Pharmacol Exp Ther. 337(1) (2011)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "GSK256066",
      "attributes": {},
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.95,
      "evidence": "GSK256066",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Mol Ther 24(12) (2016)",
      "attributes": {
        "year": 2016,
        "doi": "10.1038/mt.2016.175"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "Mol Ther. 24(12) (2016)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Clin Transl Sci 10(3) (2017)",
      "attributes": {
        "year": 2017,
        "doi": "10.1111/cts.12436"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "Clin Transl Sci. 10(3) (2017)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "TAK-648",
      "attributes": {},
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.95,
      "evidence": "TAK-648",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "type 2 diabetes",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "Type 2 Diabetes",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Ther Adv Musculoskelet Dis 2(5) (2010)",
      "attributes": {
        "year": 2010,
        "doi": "10.1177/1759720X10381432"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "Ther Adv Musculoskelet Dis. 2(5) (2010)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "apremilast",
      "attributes": {},
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.95,
      "evidence": "Apremilast",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "autoimmune and inflammatory diseases",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "autoimmune and inflammatory diseases",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Int J Mol Sci 18(4) (2017)",
      "attributes": {
        "year": 2017,
        "doi": "10.3390/ijms18040696"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "Int J Mol Sci. 18 (4) (2017)",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Curr Pharm Des 21(3) (2014)",
      "attributes": {
        "year": 2014,
        "doi": "10.2174/1381612820666140826113731"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "Curr Pharm Des. 21(3) (2014)",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Condition",
      "name": "traumatic brain injury",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "confidence": 0.9,
      "evidence": "Traumatic Brain Injury",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "phosphodiesterase-4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.95,
      "evidence": "phosphodiesterase-4 as a therapeutic target",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4D3",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.9,
      "evidence": "cAMP phosphodiesterase-4D3 (PDE4D3)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cGMP-specific phosphodiesterase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.85,
      "evidence": "cGMP-specific phosphodiesterase",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.9,
      "evidence": "target for the development of antidepressant drugs",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Houslay et al. 2005",
      "attributes": {
        "year": 2005,
        "doi": "10.1016/S1359-6446(05)03622-6"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.8,
      "evidence": "M.D. Houslay, P. Schafer, K.Y.J. Zhang, Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today. 10(22) (2005):1503\u201319.",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Houslay et al. 2010",
      "attributes": {
        "year": 2010,
        "doi": "10.1016/j.tibs.2009.09.007"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.8,
      "evidence": "M.D. Houslay, Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem Sci. 35(2) (2010):91\u2013100.",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Hill et al. 2006",
      "attributes": {
        "year": 2006,
        "doi": "10.1016/j.cellsig.2006.07.018"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.8,
      "evidence": "E.V. Hill, C.L. Sheppard, Y.F. Cheung, I. Gall, E. Krause, M.D. Houslay, Oxidative stress employs phosphatidyl inositol 3-kinase and ERK signalling pathways to activate cAMP phosphodiesterase-4D3 (PDE4D3) through multi-site phosphorylation at Ser239 and Ser579. Cell Signal. 18(11) (2006):2056\u201369.",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Zhang 2009",
      "attributes": {
        "year": 2009,
        "doi": "10.2174/138161209788168092"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.8,
      "evidence": "H.T. Zhang, Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr Pharm Des. 15(14) (2009):1688\u201398.",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Xu et al. 2000",
      "attributes": {
        "year": 2000,
        "doi": "10.1126/science.288.5472.1822"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.8,
      "evidence": "R.X. Xu, A.M. Hassell, D. Vanderwall, M.H. Lambert, W.D. Holmes, M.A. Luther, et al. Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Science. 288(5472) (2000):1822\u20135.",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Wang et al. 2007",
      "attributes": {
        "year": 2007,
        "doi": "10.1042/BJ20070970"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.8,
      "evidence": "H. Wang, M.S. Peng, Y. Chen, J. Geng, H. Robinson, M.D. Houslay, et al. Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochem J. 408 (2007):193\u2013201.",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Francis et al. 1994",
      "attributes": {
        "year": 1994
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.8,
      "evidence": "S.H. Francis, J.L. Colbran, L.M. McAllister-Lucas, J.D. Corbin, Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase. J Biol Chem. 269 (36) (1994):22477\u201380.",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "McAllister-Lucas et al. 1995",
      "attributes": {
        "year": 1995,
        "doi": "10.1074/jbc.270.51.30671"
      },
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "confidence": 0.8,
      "evidence": "L.M. McAllister-Lucas, T.L. Haik, J.L. Colbran, W.K. Sonnenburg, D. Seger, I.V. Turko, et al. An Essential Aspartic Acid at Each of Two Allosteric cGMP-binding Sites of a cGMP-specific Phosphodiesterase. J Biol Chem. 270(51) (1995):30671\u20139.",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "confidence": 0.9,
      "evidence": "cAMP-specific phosphodiesterase, PDE-4D3",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "cAMP/CREB signaling system",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "confidence": 0.85,
      "evidence": "cAMP/CREB signaling system",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "cognition enhancement",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "confidence": 0.8,
      "evidence": "cognition enhancement",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "cognitive deficits",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "confidence": 0.85,
      "evidence": "cognitive deficits",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "confidence": 0.7,
      "evidence": "in situ hybridization histochemistry",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Jabaris et al. 2015",
      "attributes": {
        "year": 2015,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "confidence": 0.8,
      "evidence": "Jabaris et al. Phosphodiesterase-4 inhibitors ameliorates cognitive deficits",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Reneerkens et al. 2009",
      "attributes": {
        "year": 2009,
        "design": "review"
      },
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "confidence": 0.8,
      "evidence": "Reneerkens et al. Selective phosphodiesterase inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Hoffmann et al. 1999",
      "attributes": {
        "year": 1999,
        "doi": "10.1093/emboj/18.4.893"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.95,
      "evidence": "R. Hoffmann, G.S. Baillie, S.J. MacKenzie, S.J. Yarwood, M.D. Houslay. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO J. 18(4) (1999):893\u2013903",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "ERK2",
      "attributes": {
        "target_type": "kinase"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.9,
      "evidence": "MAP kinase ERK2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "HSPDE4D3",
      "attributes": {
        "target_type": "phosphodiesterase"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.9,
      "evidence": "cyclic AMP-specific phosphodiesterase HSPDE4D3",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Patterson et al. 2001",
      "attributes": {
        "year": 2001,
        "doi": "10.1016/s0896-6273(01)00443-3"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.95,
      "evidence": "S.L. Patterson, C. Pittenger, A. Morozov, K.C. Martin, H. Scanlin, C. Drake, et al. Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase. Neuron. 32(1) (2001):123\u201340",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "MAP kinase",
      "attributes": {
        "target_type": "kinase"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.85,
      "evidence": "phospho-MAP kinase",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Stork & Schmitt 2002",
      "attributes": {
        "year": 2002,
        "doi": "10.1016/s0962-8924(02)02294-8"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.95,
      "evidence": "P.J.S. Stork, J.M. Schmitt. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12(6) (2002):258\u201366",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Anjum & Blenis 2008",
      "attributes": {
        "year": 2008,
        "doi": "10.1038/nrm2509"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.95,
      "evidence": "R. Anjum, J. Blenis, The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol. 9(10) (2008):747\u201358",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "RSK family of kinases",
      "attributes": {
        "target_type": "kinase"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.9,
      "evidence": "RSK family of kinases",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Gao et al. 2004",
      "attributes": {
        "year": 2004,
        "doi": "10.1016/j.neuron.2004.10.030"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.95,
      "evidence": "Y. Gao, K. Deng, J. Hou, J.B. Bryson, A. Barco, E. Nikulina, et al. Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron. 44(4) (2004):609\u201321",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "CREB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.9,
      "evidence": "Activated CREB",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Song et al. 2013",
      "attributes": {
        "year": 2013,
        "doi": "10.1073/pnas.1311783110"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.95,
      "evidence": "R.S. Song, B Massenburg, W. Wenderski, V. Jayaraman, L. Thompson, S.R. Neves. ERK regulation of phosphodiesterase 4 enhances dopamine-stimulated AMPA receptor membrane insertion. Proc Natl Acad Sci U S A. 110 (38) (2013) :15437\u201342",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "phosphodiesterase"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Miyamoto 2006",
      "attributes": {
        "year": 2006,
        "doi": "10.1254/jphs.cpj06007x"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.95,
      "evidence": "E. Miyamoto, Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus. J Pharmacol Sci. 100(5) (2006):433\u201342",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Navakkode et al. 2005",
      "attributes": {
        "year": 2005,
        "doi": "10.1523/JNEUROSCI.2443-05.2005"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.95,
      "evidence": "S. Navakkode, S. Sajikumar, J.U. Frey, Mitogen-activated protein kinase-mediated reinforcement of hippocampal early long-term depression by the type IV-specific phosphodiesterase inhibitor rolipram and its effect on synaptic tagging. J Neurosci. 25(46) (2005):10664\u201370",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase inhibitor rolipram",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "mitogen-activated protein kinase",
      "attributes": {
        "target_type": "kinase"
      },
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "confidence": 0.85,
      "evidence": "Mitogen-activated protein kinase-mediated",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "P\u00e9rez-Torres et al. 2003",
      "attributes": {
        "year": 2003,
        "doi": "10.1016/s0014-4886(03)00042-6"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.95,
      "evidence": "S. P\u00e9rez-Torres, R. Cort\u00e9s, M. Tolnay, A. Probst, J.M. Palacios, G. Mengod. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp Neurol. 182(2) (2003):322\u201334.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Carlyle et al. 2014",
      "attributes": {
        "year": 2014,
        "doi": "10.1073/pnas.1322360111"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.95,
      "evidence": "B.C. Carlyle, A.C. Nairn, M. Wang, Y. Yang, L.E. Jin, A.A. Simen, et al. cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex. Proc Natl Acad Sci U S A. 111(13) (2014):5036\u201341.",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Bonkale et al. 1999",
      "attributes": {
        "year": 1999,
        "doi": "10.1016/s0006-8993(98)01307-9"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.95,
      "evidence": "W.L. Bonkale, R.F. Cowburn, T.G. Ohm, N. Bogdanovic, J. Fastbom, A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits. Brain Res. 818(2) (1999):383\u201396.",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Garc\u00eda-Jim\u00e9nez et al. 1999",
      "attributes": {
        "year": 1999,
        "doi": "10.1016/s0006-8993(99)02111-3"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.95,
      "evidence": "A. Garc\u00eda-Jim\u00e9nez, R.F. Cowburn, T.G. Ohm, N. Bogdanovic, B. Winblad, J. Fastbom. Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits. Brain Res. 850(1\u20132) (1999):104\u201317.",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Liang et al. 2007",
      "attributes": {
        "year": 2007,
        "doi": "10.1111/j.1471-4159.2007.04942.x"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.95,
      "evidence": "Z. Liang, F. Liu, I. Grundke-Iqbal, K. Iqbal, C.X. Gong. Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J Neurochem 103(6) (2007):2462\u201370.",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Gong et al. 2004",
      "attributes": {
        "year": 2004,
        "doi": "10.1172/JCI22831"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.95,
      "evidence": "B. Gong, O.V. Vitolo, F. Trinchese, S. Liu, M. Shelanski, O. Arancio, Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest. 114(11) (2004):1624\u201334.",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Smith et al. 2009",
      "attributes": {
        "year": 2009,
        "doi": "10.1073/pnas.0908706106"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.95,
      "evidence": "D.L. Smith, J. Pozueta, B. Gong, O. Arancio, M. Shelanski. Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proc Natl Acad Sci U S A 106(39) (2009):16877\u201382.",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "Alzheimer's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.95,
      "evidence": "Alzheimer's disease brains",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "phosphodiesterase type 7",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase type 7",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "phosphodiesterase type 8",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.9,
      "evidence": "phosphodiesterase type 8",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "cAMP-dependent protein kinase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.9,
      "evidence": "cAMP-dependent protein kinase",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "calpain",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.85,
      "evidence": "over-activated calpain",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.9,
      "evidence": "rolipram treatment",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "improvement in synaptic and cognitive functions",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.85,
      "evidence": "improvement in synaptic and cognitive functions",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "reversal of long-term dendritic spine alterations",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "confidence": 0.85,
      "evidence": "Reversal of long-term dendritic spine alterations",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Salou et al. 2015",
      "attributes": {
        "year": 2015,
        "doi": "10.1002/acn3.199"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "M. Salou, A. Garcia, et al. 2015",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.8,
      "evidence": "Ann Clin Transl Neurol",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "multiple sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.95,
      "evidence": "multiple sclerosis",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Deshpande et al. 2006",
      "attributes": {
        "year": 2006,
        "doi": "10.1016/j.jneuroim.2005.11.016"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "P. Deshpande, I.L. King, et al. 2006",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "animal model study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.8,
      "evidence": "animal model of autoimmune demyelination",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "autoimmune demyelination",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "autoimmune demyelination",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Trenova et al. 2018",
      "attributes": {
        "year": 2018,
        "doi": "10.1080/01616412.2017.1420522"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "A.G. Trenova, G.S. Slavov, et al. 2018",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.8,
      "evidence": "Neurol Res",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "relapsing-remitting multiple sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.95,
      "evidence": "relapsing-remitting multiple sclerosis",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Kopper & Gensel 2018",
      "attributes": {
        "year": 2018,
        "doi": "10.1002/jnr.24114"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "T.J. Kopper, J.C. Gensel 2018",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.8,
      "evidence": "J Neurosci Res",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "spinal cord injury",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "spinal cord injury",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Bopp et al. 2007",
      "attributes": {
        "year": 2007,
        "doi": "10.1080/07853890701379700"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "T. Bopp, H. Jonuleit, et al. 2007",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 5
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.8,
      "evidence": "Ann Med",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Maida & Kristoferitsch 1981",
      "attributes": {
        "year": 1981,
        "doi": "10.1007/bf00313327"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "E. Maida, W. Kristoferitsch 1981",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.8,
      "evidence": "J Neurol",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Study",
      "name": "Khezri et al. 2013",
      "attributes": {
        "year": 2013,
        "doi": "10.1007/s12031-013-9959-x"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "S. Khezri, M. Javan, et al. 2013",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Evidence",
      "name": "animal model study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.8,
      "evidence": "experimental autoimmune encephalomyelitis",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Condition",
      "name": "experimental autoimmune encephalomyelitis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.95,
      "evidence": "experimental autoimmune encephalomyelitis",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Study",
      "name": "Duarte-Silva et al. 2018",
      "attributes": {
        "year": 2018,
        "doi": "10.1016/j.jneuroim.2018.06.002"
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.9,
      "evidence": "E. Duarte-Silva, R. Ara\u00fajo, et al. 2018",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Evidence",
      "name": "animal model study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "confidence": 0.8,
      "evidence": "EAE in C57BL/6 mice",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Psychopharmacology (Berl) 159(1) 2001",
      "attributes": {
        "year": 2001,
        "doi": "https://doi.org/10.1007/s002130100889"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.9,
      "evidence": "Psychopharmacology (Berl). 159(1) (2001); 89\u201397",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Pharmacol Res. 41(4) 2000",
      "attributes": {
        "year": 2000,
        "doi": "https://doi.org/10.1006/phrs.1999.0609"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.9,
      "evidence": "Pharmacol Res. 41(4) (2000); 435\u201343",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "EMBO J. 27(2) 2008",
      "attributes": {
        "year": 2008,
        "doi": "https://doi.org/10.1038/sj.emboj.7601968"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.9,
      "evidence": "EMBO J. 27(2) (2008); 384\u201393",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Psychopharmacology (Berl) 182(1) 2005",
      "attributes": {
        "year": 2005,
        "doi": "https://doi.org/10.1007/s00213-005-0055-y"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.9,
      "evidence": "Psychopharmacology (Berl). 182(1) (2005); 104\u201315",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Mol Psychiatry. 22(5) 2017",
      "attributes": {
        "year": 2017,
        "doi": "https://doi.org/10.1038/mp.2016.171"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.9,
      "evidence": "Mol Psychiatry. 22(5) (2017); 754\u20139",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Journal of Pharmacology and Pharmacotherapeutics 3(2) 2012",
      "attributes": {
        "year": 2012,
        "doi": "https://doi.org/10.4103/0976-500X.95509"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.9,
      "evidence": "Journal of Pharmacology and Pharmacotherapeutics. 3(2) (2012); 132",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Scientific Reports 5 2015",
      "attributes": {
        "year": 2015,
        "doi": "https://doi.org/10.1038/srep11332"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.9,
      "evidence": "Scientific Reports 5 (2015); 11332",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.7,
      "evidence": "rats, mice",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "beta(1)-adrenoceptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.85,
      "evidence": "beta(1)- and beta(2)-adrenoceptor subtypes",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "beta(2)-adrenoceptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.85,
      "evidence": "beta(1)- and beta(2)-adrenoceptor subtypes",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.9,
      "evidence": "PDE4",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "cAMP signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.8,
      "evidence": "cAMP signaling in brain",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "Phosphodiesterase-4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.85,
      "evidence": "Phosphodiesterase-4D",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.85,
      "evidence": "depressed patients, depressive-like behaviors",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "antidepressant-like behavioral effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.8,
      "evidence": "antidepressant-like behavioral effects",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "decreased cAMP signaling",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.75,
      "evidence": "cAMP signaling in brain is decreased",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "alleviates depressive-like behaviors",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.8,
      "evidence": "alleviates chronic unpredictable stress-induced depressive-like behaviors",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "alleviates memory deficits",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "confidence": 0.8,
      "evidence": "alleviates memory deficits",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Zhang et al. 2017",
      "attributes": {
        "year": 2017,
        "doi": "10.1038/srep40115"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.9,
      "evidence": "C. Zhang, Y. Xu, H.T. Zhang, M.E. Gurney, J.M. O'Donnell. Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System. Scientific Reports. 7 (2017):40115",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.85,
      "evidence": "Comparison of the Pharmacological Profiles",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.9,
      "evidence": "Selective PDE4B and PDE4D Inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.9,
      "evidence": "Selective PDE4B and PDE4D Inhibitors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Sasaki et al. 2007",
      "attributes": {
        "year": 2007,
        "doi": "10.1161/STROKEAHA.106.476754"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.9,
      "evidence": "T. Sasaki, K. Kitagawa, E. Omura-Matsuoka, K. Todo, Y. Terasaki, S. Sugiura, et al. The phosphodiesterase inhibitor rolipram promotes survival of newborn hippocampal neurons after ischemia. Stroke. 38(5) (2007):1597\u2013605",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "in vivo",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.85,
      "evidence": "promotes survival of newborn hippocampal neurons after ischemia",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.95,
      "evidence": "phosphodiesterase inhibitor rolipram",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "ischemia",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.9,
      "evidence": "after ischemia",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "neuronal survival",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.85,
      "evidence": "promotes survival of newborn hippocampal neurons",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "DeMarch et al. 2008",
      "attributes": {
        "year": 2008,
        "doi": "10.1016/j.nbd.2008.02.010"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.9,
      "evidence": "Z. DeMarch, C. Giamp\u00e0, S. Patassini, G. Bernardi, F.R. Fusco. Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. Neurobiol Dis. 30(3) (2008):375\u201387",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "animal model",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.85,
      "evidence": "R6/2 mouse model of Huntington's disease",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "Huntington's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.95,
      "evidence": "Huntington's disease",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "beneficial effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "confidence": 0.8,
      "evidence": "Beneficial effects of rolipram",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "blood-brain-barrier damage",
      "attributes": {},
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.9,
      "evidence": "blood-brain-barrier damage",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "inflammation",
      "attributes": {},
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.9,
      "evidence": "inflammation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "thrombosis",
      "attributes": {},
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.9,
      "evidence": "thrombosis",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Exp Neurol. 247 (2013):80\u201390",
      "attributes": {
        "year": 2013,
        "doi": "https://doi.org/10.1016/j.expneurol.2013.03.026"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "Exp Neurol. 247 (2013):80\u201390",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "amyotrophic lateral sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.95,
      "evidence": "amyotrophic lateral sclerosis",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Amyotroph Lateral Scler Frontotemporal Degener. 14 (2013):19\u201332",
      "attributes": {
        "year": 2013,
        "doi": "https://doi.org/10.3109/21678421.2013.778554"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "Amyotroph Lateral Scler Frontotemporal Degener. 14 (2013):19\u201332",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "VAPB",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.8,
      "evidence": "mutation in VAPB",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "J Biol Chem. 285(51) (2010):40266\u201381",
      "attributes": {
        "year": 2010,
        "doi": "https://doi.org/10.1074/jbc.M110.161398"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "J Biol Chem. 285(51) (2010):40266\u201381",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "TDP-43",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "TDP-43 mutations",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Science. 319(5870) (2008):1668\u201372",
      "attributes": {
        "year": 2008,
        "doi": "https://doi.org/10.1126/science.1154584"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "Science. 319(5870) (2008):1668\u201372",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "kynurenine pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.8,
      "evidence": "Kynurenine pathway metabolism",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "J Neurochem. 78(4) (2001):842\u201353",
      "attributes": {
        "year": 2001,
        "doi": "https://doi.org/10.1046/j.1471-4159.2001.00498.x"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "J Neurochem. 78(4) (2001):842\u201353",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "quinolinic acid",
      "attributes": {},
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.9,
      "evidence": "quinolinic acid",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Neuropharmacology. 112 (2017):346\u201364",
      "attributes": {
        "year": 2017,
        "doi": "https://doi.org/10.1016/j.neuropharm.2016.05.011"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "Neuropharmacology. 112 (2017):346\u201364",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "glial cells",
      "attributes": {
        "target_type": "cellular"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.8,
      "evidence": "Glial Cells",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "J Clin Med. 9(1) (2020):261",
      "attributes": {
        "year": 2020,
        "doi": "https://doi.org/10.3390/jcm9010261"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "J Clin Med. 9(1) (2020):261",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.9,
      "evidence": "ibudilast",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Target",
      "name": "SOD1",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.8,
      "evidence": "clearance of SOD1",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Target",
      "name": "TFEB",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.8,
      "evidence": "TFEB-mediated autophagy",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Study",
      "name": "Biochem Biophys Res Commun. 526(1) (2020):231\u20138",
      "attributes": {
        "year": 2020,
        "doi": "https://doi.org/10.1016/j.bbrc.2020.03.051"
      },
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "confidence": 0.85,
      "evidence": "Biochem Biophys Res Commun. 526(1) (2020):231\u20138",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Ramezani et al. 2017",
      "attributes": {
        "year": 2017,
        "doi": "https://doi.org/10.1016/j.lfs.2017.02.005"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.95,
      "evidence": "S. Ramezani, N. Vousooghi, et al. 2017",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.8,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.9,
      "evidence": "Rolipram potentiates bevacizumab",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "glioblastoma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.85,
      "evidence": "glioblastoma stem-like cells",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "cell death",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.8,
      "evidence": "bevacizumab-induced cell death",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Kang et al. 2014",
      "attributes": {
        "year": 2014,
        "doi": "https://doi.org/10.1038/srep05546"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.95,
      "evidence": "T.W. Kang, S.W. Choi, et al. 2014",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.8,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "glioblastoma multiforme",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.9,
      "evidence": "glioblastoma multiforme",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Yang et al. 2007",
      "attributes": {
        "year": 2007,
        "doi": "https://doi.org/10.1158/0008-5472.CAN-06-2762"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.95,
      "evidence": "Yang L, Jackson E, et al. 2007",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.85,
      "evidence": "in vivo",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "brain tumor",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.8,
      "evidence": "brain tumor growth",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Titus et al. 2013",
      "attributes": {
        "year": 2013,
        "doi": "https://doi.org/10.1523/JNEUROSCI.5133-12.2013"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.95,
      "evidence": "D.J. Titus, A. Sakurai, et al. 2013",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.85,
      "evidence": "in vivo",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "traumatic brain injury",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.9,
      "evidence": "traumatic brain injury",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "cognitive deficits",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.85,
      "evidence": "chronic cognitive deficits",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Nagakura et al. 2002",
      "attributes": {
        "year": 2002,
        "doi": "https://doi.org/10.1038/sj.bjp.0704629"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.95,
      "evidence": "A. Nagakura, M. Niimura, et al. 2002",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.85,
      "evidence": "in vivo",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Condition",
      "name": "memory function defects",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.8,
      "evidence": "defects in memory function",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Study",
      "name": "Ghosh et al. 2012",
      "attributes": {
        "year": 2012,
        "doi": "https://doi.org/10.1002/glia.22401"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.95,
      "evidence": "M. Ghosh, D. Garcia-Castillo, et al. 2012",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.8,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Condition",
      "name": "CNS injury",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "confidence": 0.85,
      "evidence": "CNS injury",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "asthma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.9,
      "evidence": "treatment of asthma",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.9,
      "evidence": "treatment of COPD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase 4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.95,
      "evidence": "phosphodiesterase 4D (PDE4D)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Burgin et al. 2010",
      "attributes": {
        "year": 2010,
        "doi": "10.1038/nbt.1598"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.85,
      "evidence": "A.B. Burgin et al. Design of phosphodiesterase 4D (PDE4D) allosteric modulators",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.8,
      "evidence": "Design of phosphodiesterase 4D (PDE4D) allosteric modulators",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Robichaud et al. 2002",
      "attributes": {
        "year": 2002,
        "doi": "10.1172/JCI15506"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.85,
      "evidence": "A. Robichaud et al. Deletion of phosphodiesterase 4D in mice",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.8,
      "evidence": "Deletion of phosphodiesterase 4D in mice",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "emesis",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.85,
      "evidence": "behavioral correlate of emesis",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Titus et al. 2018",
      "attributes": {
        "year": 2018,
        "doi": "10.1016/j.nlm.2017.12.008"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.85,
      "evidence": "Titus et al. A negative allosteric modulator of PDE4D enhances learning",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.8,
      "evidence": "enhances learning after traumatic brain injury",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "traumatic brain injury",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.9,
      "evidence": "after traumatic brain injury",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Sutcliffe et al. 2014",
      "attributes": {
        "year": 2014,
        "doi": "10.1371/journal.pone.0102449"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.85,
      "evidence": "Sutcliffe et al. Efficacy of Selective PDE4D Negative Allosteric Modulators",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.8,
      "evidence": "in Female Cynomolgus Monkeys",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Xu et al. 2019",
      "attributes": {
        "year": 2019,
        "doi": "10.1096/fasebj.2019.33.1_supplement.806.4"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.85,
      "evidence": "Xu et al. A selective phosphodiesterase 4D inhibitor BPN14770",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.8,
      "evidence": "in humanized PDE4D mice",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Condition",
      "name": "memory impairment",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.85,
      "evidence": "reverses beta amyloid-induced memory impairment",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Study",
      "name": "Trifilieff et al. 2002",
      "attributes": {
        "year": 2002,
        "doi": "10.1124/jpet.301.1.241"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.85,
      "evidence": "Trifilieff et al. Pharmacological profile of a novel phosphodiesterase 4 inhibitor",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.8,
      "evidence": "with anti-inflammatory activities",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Condition",
      "name": "inflammation",
      "attributes": {
        "condition_type": "process"
      },
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "confidence": 0.8,
      "evidence": "anti-inflammatory activities",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.95,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "alcohol-induced steatosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.9,
      "evidence": "alcohol-induced steatosis",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "kidney fibrosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.9,
      "evidence": "kidney fibrosis",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "neuroinflammation",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.9,
      "evidence": "neuroinflammation",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "allergic asthma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.9,
      "evidence": "allergic asthma",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "prostate cancer",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.9,
      "evidence": "prostate cancer",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Avila et al. 2016",
      "attributes": {
        "year": 2016,
        "doi": "10.1002/path.4760"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.85,
      "evidence": "D.V. Avila et al. 2016",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Schinner et al. 2015",
      "attributes": {
        "year": 2015,
        "doi": "10.3390/ijms16022320"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.85,
      "evidence": "E. Schinner et al. 2015",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Komatsu et al. 2013",
      "attributes": {
        "year": 2013,
        "doi": "10.1038/ncomms2674"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.85,
      "evidence": "K. Komatsu et al. 2013",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Pearse & Hughes 2016",
      "attributes": {
        "year": 2016,
        "doi": "10.1002/glia.22986"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.85,
      "evidence": "D.D. Pearse, Z.A. Hughes 2016",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Jin et al. 2010",
      "attributes": {
        "year": 2010,
        "doi": "10.1016/j.jaci.2010.08.014"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.85,
      "evidence": "S.L.C. Jin et al. 2010",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Kashiwagi et al. 2012",
      "attributes": {
        "year": 2012,
        "doi": "10.1002/pros.21478"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.85,
      "evidence": "E. Kashiwagi et al. 2012",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.8,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.8,
      "evidence": "in mice",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "CP-80,633",
      "attributes": {},
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.9,
      "evidence": "CP-80,633",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "increased plasma cyclic AMP levels",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.85,
      "evidence": "elevates plasma cyclic AMP levels",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "decreased TNF-alpha production",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "confidence": 0.85,
      "evidence": "decreases tumor necrosis factor-alpha (TNFalpha) production",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Lira et al. 2010",
      "attributes": {
        "year": 2010,
        "design": "experimental"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.9,
      "evidence": "E.C. Lira, L.T. Parreiras-e-Silva, N.M. Zanon, C.M. da Costa Neto, I. do Carmo Kettelhut, L.C.C. Navegantes. The inhibition of phosphodiesterase 4 reduces skeletal muscle protein catabolism",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.8,
      "evidence": "The FASEB Journal",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.95,
      "evidence": "phosphodiesterase 4",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduced skeletal muscle protein catabolism",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.85,
      "evidence": "reduces skeletal muscle protein catabolism",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Huang et al. 2013",
      "attributes": {
        "year": 2013,
        "doi": "https://doi.org/10.1016/j.bbrc.2013.11.004"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.9,
      "evidence": "Z. Huang, Z. Han, W. Cui, F. Zhang, H. He, T. Zeng, et al. Dynamic expression pattern of Pde4d",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "Pde4d",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.95,
      "evidence": "Pde4d",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Levallet et al. 2007",
      "attributes": {
        "year": 2007,
        "doi": "https://doi.org/10.1095/biolreprod.106.055343"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.9,
      "evidence": "G. Levallet, J. Levallet, H. Boura\u00efma-Lelong, P.J. Bonnamy. Expression of the cAMP-Phosphodiesterase PDE4D Isoforms",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Gr\u00f8nning et al. 2006",
      "attributes": {
        "year": 2006,
        "doi": "https://doi.org/10.1016/j.febslet.2006.06.058"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.9,
      "evidence": "L.M. Gr\u00f8nning, G.S. Baillie, A. Cederberg, M.J. Lynch, M.D. Houslay, S. Enerb\u00e4ck, et al. Reduced PDE4 expression and activity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "enhanced catecholamine-induced cAMP accumulation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.85,
      "evidence": "enhanced catecholamine-induced cAMP accumulation",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Lin et al. 2013",
      "attributes": {
        "year": 2013,
        "doi": "https://doi.org/10.1073/pnas.1218206110"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.9,
      "evidence": "D.C. Lin, L. Xu, L.W. Ding, A. Sharma, L.Z. Liu, H. Yang, et al. Genomic and functional characterizations of phosphodiesterase subtype 4D",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "human cancers",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.85,
      "evidence": "human cancers",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Mishra et al. 2018",
      "attributes": {
        "year": 2018,
        "doi": "https://doi.org/10.1158/1078-0432.CCR-17-2776"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.9,
      "evidence": "R.R. Mishra, N. Belder, S.A. Ansari, M. Kayhan, H. Bal, U. Raza, et al. Reactivation of cAMP Pathway by PDE4D Inhibition",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "Tamoxifen Resistance in ER-positive Breast Cancer",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.9,
      "evidence": "Tamoxifen Resistance in ER-positive Breast Cancer",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Richter et al. 2005",
      "attributes": {
        "year": 2005,
        "doi": "https://doi.org/10.1042/BJ20050030"
      },
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "confidence": 0.9,
      "evidence": "W. Richter, S.L.C. Jin, M. Conti. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4 Long isoform",
      "attributes": {
        "target_type": "protein isoform"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.9,
      "evidence": "Long isoform: PKA phosphorylation site",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4 Short isoform",
      "attributes": {
        "target_type": "protein isoform"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.9,
      "evidence": "Short isoform: UCR2, Catalytic unit",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4 Super short isoform",
      "attributes": {
        "target_type": "protein isoform"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.9,
      "evidence": "Super short isoform: UCR2, Catalytic unit",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "UCR1 domain",
      "attributes": {
        "target_type": "protein domain"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.85,
      "evidence": "Long isoform additionally includes a green UCR1 domain",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "UCR2 domain",
      "attributes": {
        "target_type": "protein domain"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.85,
      "evidence": "pink UCR2 domain",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "catalytic unit",
      "attributes": {
        "target_type": "protein domain"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.85,
      "evidence": "blue catalytic unit",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "C-terminal tail",
      "attributes": {
        "target_type": "protein domain"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.85,
      "evidence": "purple C-terminal tail",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "N-terminal domain",
      "attributes": {
        "target_type": "protein domain"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.85,
      "evidence": "yellow N-terminal domain",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "PKA phosphorylation site",
      "attributes": {
        "target_type": "phosphorylation site"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.8,
      "evidence": "PKA phosphorylation site is located on the UCR1 domain",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "ERK phosphorylation site",
      "attributes": {
        "target_type": "phosphorylation site"
      },
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "confidence": 0.8,
      "evidence": "ERK phosphorylation site is located on the catalytic unit",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PKA",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bf484e0f0258178462ab6c227c7916c2"
      ],
      "confidence": 0.8,
      "evidence": "regulated by PKA",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "ERK 1/2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bf484e0f0258178462ab6c227c7916c2"
      ],
      "confidence": 0.8,
      "evidence": "ERK 1/2 phosphorylation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Cedervall et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "bf484e0f0258178462ab6c227c7916c2"
      ],
      "confidence": 0.9,
      "evidence": "Cedervall et al., 2015",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "bf484e0f0258178462ab6c227c7916c2"
      ],
      "confidence": 0.7,
      "evidence": "regulated by PKA and ERK 1/2 phosphorylation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "16be5d122eb5ea4e77d05f2008c73d63"
      ],
      "confidence": 0.8,
      "evidence": "PDE4 subfamily members 4A",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "16be5d122eb5ea4e77d05f2008c73d63"
      ],
      "confidence": 0.8,
      "evidence": "PDE4 subfamily members 4B",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "16be5d122eb5ea4e77d05f2008c73d63"
      ],
      "confidence": 0.8,
      "evidence": "PDE4 subfamily members 4C",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "16be5d122eb5ea4e77d05f2008c73d63"
      ],
      "confidence": 0.8,
      "evidence": "PDE4 subfamily members 4D",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "MPP+",
      "attributes": {},
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.95,
      "evidence": "MPP+ enters the cell",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "cAMP/PKA/CREB signaling pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.9,
      "evidence": "cAMP/PKA/CREB signaling pathways",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "Epac/Akt signaling pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.9,
      "evidence": "Epac/Akt signaling pathways",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decrease in mitochondrial membrane potential",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.85,
      "evidence": "decrease in mitochondrial membrane potential",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increase in reactive oxygen species",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.85,
      "evidence": "increase in reactive oxygen species",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "Bcl-2",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.85,
      "evidence": "decrease in the level of Bcl-2",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "Bax",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.85,
      "evidence": "expression of Bax is increased",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "caspase 3",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.85,
      "evidence": "activation of caspase 3",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "neurodegeneration",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.9,
      "evidence": "leading to neurodegeneration",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors (PDE4-I)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "confidence": 0.8,
      "evidence": "increasing the level of cAMP",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "1-methyl-4-phenylpyridinium",
      "attributes": {},
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.95,
      "evidence": "1-methyl-4-phenylpyridinium (MPP+)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "accumulation of reactive oxygen species",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.9,
      "evidence": "triggers the accumulation of reactive oxygen species (ROS)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reduces mitochondrial membrane potential",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.9,
      "evidence": "reduces mitochondrial membrane potential (MMP)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "increase in expression of Bax",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.85,
      "evidence": "increase in expression of Bax",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "decrease in the level of Bcl-2",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.85,
      "evidence": "decrease in the level of Bcl-2",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "levels of cleaved caspase 3 are increased",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.85,
      "evidence": "levels of cleaved caspase 3 are also increased",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "neurodegeneration",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.9,
      "evidence": "leads to neurodegeneration",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "cAMP/PKA/CREB signalling pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.85,
      "evidence": "cAMP/PKA/CREB signalling pathway",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "Epac/Akt signalling pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.85,
      "evidence": "Epac/Akt signalling pathway",
      "verified": true
    },
    {
      "id": "E10",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "increasing the level of cAMP",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.85,
      "evidence": "increasing the level of cAMP",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "activates cAMP/PKA/CREB and Epac/Akt signalling pathways",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.85,
      "evidence": "activates cAMP/PKA/CREB and Epac/Akt signalling pathways",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "prevents neurodegeneration",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "confidence": 0.9,
      "evidence": "prevents neurodegeneration",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "GPCR",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "GPCR (G protein-coupled receptor)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "Gs subunit",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.9,
      "evidence": "activation of the Gs subunit",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "Adenylate Cyclase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "Adenylate Cyclase (AC)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "cAMP molecule",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Protein Kinase A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "Protein Kinase A (PKA)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "Epac",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.9,
      "evidence": "Exchange Protein directly activated by cAMP (Epac)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "CREB",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "CREB (cAMP-responsive element-binding protein)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "BDNF",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "BDNF (Brain-Derived Neurotrophic Factor)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "Neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.85,
      "evidence": "Neurogenesis (orange box)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "Neuroplasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.85,
      "evidence": "Neuroplasticity (orange box)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "ERK1/2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "ERK1/2 (Extracellular signal-Regulated Kinase 1/2)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.9,
      "evidence": "IL-1\u03b2 (Interleukin-1 beta)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "stroke",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "STROKE",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 (Phosphodiesterase 4)",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "PDE4 inhibitor",
      "attributes": {},
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "confidence": 0.85,
      "evidence": "PDE4I (PDE4 inhibitor)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "GPCR",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.9,
      "evidence": "Activation of GPCR",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "G\\alpha subunit",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "activates G\\alpha subunit",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "adenylyl cyclase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "adenylyl cyclase (AC)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cAMP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.9,
      "evidence": "conversion of ATP to cAMP",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "protein kinase A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "activation of protein kinase A (PKA)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "Epac",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "exchange proteins activated by cAMP (Epac)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "CREB",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "cAMP-responsive element-binding protein (CREB)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "stroke",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.9,
      "evidence": "Under stroke conditions",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.9,
      "evidence": "over expression of PDE4 in brain",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "PKA/CREB signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.8,
      "evidence": "inhibits PKA/CREB",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "Epac/ERK1/2 signalling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.8,
      "evidence": "Epac/ERK1/2 signalling",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "cAMP/PKA/CREB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.8,
      "evidence": "Activation of cAMP/PKA/CREB",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "BDNF",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "neurotrophic factors like BDNF",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "Epac/ERK1/2",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.8,
      "evidence": "Epac/ERK1/2 activation",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "proinflammatory factors",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.8,
      "evidence": "inhibits proinflammatory factors",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "PDE4 inhibitors",
      "attributes": {
        "target_type": "compound_class"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors act",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "role in neurogenesis",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "neuroplasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "confidence": 0.85,
      "evidence": "neuroplasticity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "Tryptophan",
      "attributes": {},
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.95,
      "evidence": "Tryptophan is converted to Kynurenine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "IDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "IDO (indoleamine 2,3-dioxygenase)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "TDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "TDO (tryptophan 2,3-dioxygenase)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "Kynurenine",
      "attributes": {},
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.95,
      "evidence": "Kynurenine is then metabolized",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "KAT",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "KAT (kynurenine aminotransferase)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "Kynurenic acid",
      "attributes": {},
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "Kynurenic acid",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "KZ",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "KZ (kynureninase)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "Anthranilic acid",
      "attributes": {},
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "Anthranilic acid",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "HK",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "HK (kynurenine 3-hydroxylase)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "3-Hydroxykynurenine",
      "attributes": {},
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "3-Hydroxykynurenine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "HAO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "HAO (3-hydroxyanthranilate-3,4-dioxygenase)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "Quinolinic acid",
      "attributes": {},
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "Quinolinic acid",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "Excitotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.85,
      "evidence": "Excitotoxicity",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "Neuroinflammation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.85,
      "evidence": "Neuroinflammation",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "Oxidative stress",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.85,
      "evidence": "Oxidative stress",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Condition",
      "name": "Motor neuron death",
      "attributes": {
        "condition_type": "pathology"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "Motor neuron death",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 enzyme",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Compound",
      "name": "Ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "confidence": 0.9,
      "evidence": "Ibudilast (PDE4 Inhibitor)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "kynurenine pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.9,
      "evidence": "Schematic representation of kynurenine pathway",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "TDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "TDO\u2014tryptophan 2,3-dioxygenase",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "IDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "IDO\u2014indoleamine 2,3-dioxygenase",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "KAT",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "KAT\u2014 kynurenine aminotransferase",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "KZ",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "KZ\u2014kynureninase",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "HK",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "HK\u2014kynurenine 3-hydroxylase",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "HAO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "HAO\u20143-hydroxyanthranilate-3,4-dioxygenase",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PC",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "PC\u2014 picolinic carboxylase",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "NC",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "NC\u2014nonenzymic cyclization",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "Quinolinic acid",
      "attributes": {},
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.9,
      "evidence": "Increase in the production of Quinolinic acid",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.9,
      "evidence": "increases the expression of PDE4",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "excitotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "leads to excitotoxicity",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "neuroinflammation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "neuroinflammation",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "oxidative stress",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "increase in the production of oxidative stress",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "ALS",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.9,
      "evidence": "neuronal loss in ALS",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "neuronal loss",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "confidence": 0.85,
      "evidence": "neuronal loss in ALS",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e17a707e368ae726035e626407eb16d6"
      ],
      "confidence": 0.95,
      "evidence": "PDE4A",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e17a707e368ae726035e626407eb16d6"
      ],
      "confidence": 0.95,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e17a707e368ae726035e626407eb16d6"
      ],
      "confidence": 0.95,
      "evidence": "PDE4C",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e17a707e368ae726035e626407eb16d6"
      ],
      "confidence": 0.95,
      "evidence": "PDE4D",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "NCT01602900",
      "attributes": {
        "design": "clinical trial",
        "phase": 1
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "NCT01602900",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "Huntington Disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Huntington Disease",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "GSK356278",
      "attributes": {},
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Drug: GSK356278",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Drug: Rolipram",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "NCT03030105",
      "attributes": {
        "design": "clinical trial",
        "phase": 3
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "NCT03030105",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "Alzheimer Disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Alzheimer Disease",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "BPN14770",
      "attributes": {},
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Drug: BPN14770",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "NCT00369798",
      "attributes": {
        "design": "clinical trial",
        "phase": 1
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "NCT00369798",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "Major Depressive Disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Major Depressive Disorder",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "NCT03861000",
      "attributes": {
        "design": "clinical trial",
        "phase": 1
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "NCT03861000",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "Depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Depression",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "[C-11]T-1650",
      "attributes": {},
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Drug: [C-11]T-1650",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "NCT01433666",
      "attributes": {
        "design": "clinical trial",
        "phase": 2
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "NCT01433666",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "Dementia",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Dementia",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "Roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "confidence": 0.95,
      "evidence": "Drug: Roflumilast",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "NCT00362024",
      "attributes": {
        "phase": "Phase 2",
        "location": "National Institutes of Health Clinical Center, Bethesda, Maryland, United States"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "NCT00362024Alzheimer's Disease\u2022 Drug: MK0952Phase 2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "Alzheimer's Disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.95,
      "evidence": "NCT00362024Alzheimer's Disease",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "MK0952",
      "attributes": {},
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "Drug: MK0952",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "NCT02840279",
      "attributes": {
        "phase": "Phase 1",
        "location": "Jasper Clinic, Kalamazoo, Michigan, United States"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "NCT02840279Alzheimer's Disease\u2022 Drug: BPN14770Phase 1",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "BPN14770",
      "attributes": {},
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "Drug: BPN14770",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "NCT01573819",
      "attributes": {
        "phase": "Phase 1",
        "location": "GSK Investigational Site, Zuidlaren, Netherlands"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "NCT01573819Huntington Disease\u2022 Drug: GSK356278Phase 1",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "Huntington Disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.95,
      "evidence": "NCT01573819Huntington Disease",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "GSK356278",
      "attributes": {},
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "Drug: GSK356278",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "NCT02835716",
      "attributes": {
        "phase": "Phase 1",
        "location": "Millennium Magnetic Technologies, LLC, Westport, Connecticut, United States"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "NCT02835716Alzheimer Disease\u2022 Drug: RoflumilastBiological: IstekinumabPhase 1",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "Alzheimer Disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.95,
      "evidence": "NCT02835716Alzheimer Disease",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "Roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "Drug: Roflumilast",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "Istekinumab",
      "attributes": {},
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "Biological: Istekinumab",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "NCT02079844",
      "attributes": {
        "phase": "Phase 1",
        "location": "Denmark Hill, London, United Kingdom"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.9,
      "evidence": "NCT02079844Schizophrenia\u2022 Drug: RoflumilastPhase 1",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "Schizophrenia",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "confidence": 0.95,
      "evidence": "NCT02079844Schizophrenia",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "NCT02051335",
      "attributes": {
        "design": "clinical trial",
        "phase": 1,
        "location": "London, United Kingdom"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "NCT02051335 Phase 1 \u2022 London, United Kingdom",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "Memory Impairment",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.9,
      "evidence": "Memory Impairment",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "Alzheimer's Disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "Alzheimer's Disease",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "Roflumilast",
      "attributes": {},
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "Drug: Roflumilast",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "NCT03782415",
      "attributes": {
        "design": "clinical trial",
        "phase": 2,
        "location": "Dana Farber Cancer Institute, Boston, Massachusetts, United States"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "NCT03782415 Phase 2 \u2022 Dana Farber Cancer Institute",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "Glioblastoma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.9,
      "evidence": "Glioblastoma",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "Recurrent Glioblastoma",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.9,
      "evidence": "Recurrent Glioblastoma",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "MN-166",
      "attributes": {},
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "Drug: MN-166",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "NCT02714036",
      "attributes": {
        "design": "clinical trial",
        "phase": 2,
        "location": "Massachusetts General Hospital, Boston, Massachusetts, United States \u2022 South Shore Neurologic Associates, P.C., Patchogue, New York, United States"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "NCT02714036 Phase 2 \u2022 Massachusetts General Hospital",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "Amyotrophic Lateral Sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "Amyotrophic Lateral Sclerosis",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "Ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "Drug: Ibudilast",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "NCT01389193",
      "attributes": {
        "design": "clinical trial",
        "phase": 1,
        "location": "School of Medical sciences, University of Adelaide, Adelaide, Australia"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.95,
      "evidence": "NCT01389193 Phase 1 \u2022 University of Adelaide",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "Migraine Headache",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "confidence": 0.9,
      "evidence": "Migraine Headache",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "NCT01982942",
      "attributes": {
        "design": "Phase 2",
        "condition": "Multiple Sclerosis, Primary Progressive"
      },
      "source_chunk_ids": [
        "f2d6b9720a7d4b7d41dfa067697fa3d5"
      ],
      "confidence": 0.95,
      "evidence": "NCT01982942 Phase 2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "f2d6b9720a7d4b7d41dfa067697fa3d5"
      ],
      "confidence": 0.85,
      "evidence": "Phase 2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "Multiple Sclerosis",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "f2d6b9720a7d4b7d41dfa067697fa3d5"
      ],
      "confidence": 0.9,
      "evidence": "Multiple Sclerosis",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "Primary Progressive",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "f2d6b9720a7d4b7d41dfa067697fa3d5"
      ],
      "confidence": 0.9,
      "evidence": "Primary Progressive",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "NCT02013310",
      "attributes": {
        "design": "Phase 2 clinical trial",
        "year": null,
        "doi": null
      },
      "source_chunk_ids": [
        "87dfc626713653a6932ea3f64088d067"
      ],
      "confidence": 0.95,
      "evidence": "NCT02013310",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "87dfc626713653a6932ea3f64088d067"
      ],
      "confidence": 0.85,
      "evidence": "Phase 2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "Age-Associated Memory Impairment",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "87dfc626713653a6932ea3f64088d067"
      ],
      "confidence": 0.9,
      "evidence": "Age-Associated Memory Impairment (AAMI)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Product",
      "name": "HT-0712",
      "attributes": {},
      "source_chunk_ids": [
        "87dfc626713653a6932ea3f64088d067"
      ],
      "confidence": 0.9,
      "evidence": "Drug: HT-0712",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Please cite this article as",
      "source_chunk_ids": [
        "2770cefdbe076e2318d24742c304acb2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "Phosphodiesterase-4 enzyme as a therapeutic target",
      "source_chunk_ids": [
        "2770cefdbe076e2318d24742c304acb2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "therapeutic_target"
      },
      "confidence": 0.8,
      "evidence": "therapeutic target in neurological disorders",
      "source_chunk_ids": [
        "2770cefdbe076e2318d24742c304acb2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cAMP levels are shown to decrease",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cAMP levels are shown to increase",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.75,
      "evidence": "cAMP levels influence Other Neurological Disorders",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.75,
      "evidence": "cAMP levels influence Stroke",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.75,
      "evidence": "cAMP levels influence Parkinson's Disease",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.75,
      "evidence": "cAMP levels influence Alzheimer's Disease",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E12",
      "target_entity_id": "E5",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "cAMP levels decrease in Other Neurological Disorders",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E13",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "cAMP levels increase in Stroke",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "SUGGESTS",
      "source_entity_id": "E13",
      "target_entity_id": "E7",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "cAMP levels increase in Parkinson's Disease",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E12",
      "target_entity_id": "E8",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "cAMP levels decrease in Alzheimer's Disease",
      "source_chunk_ids": [
        "e41bdaa6ceb8f8be10f07fdad48698fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "roflumilast was approved for the treatment of COPD",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "roflumilast, a PDE4 inhibitor",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "apremilast approved for psoriasis",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors like apremilast",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors like crisaborole",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "adverse effects like unbearable nausea",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E11",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "adverse effects like vomiting",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E12",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "dose intolerance",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E13",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "diarrhoea",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E19",
      "target_entity_id": "E5",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "review on effects of PDE4 overexpression in neurological disorders",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E20",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "compiled a list of on-going clinical trials",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E20",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.7,
      "evidence": "clinical trials on PDE4 inhibitors",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E20",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "clinical trials on PDE4 inhibitors in neurological disorders",
      "source_chunk_ids": [
        "bb7de4c5a5e0fb0d6dc19d37272889fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE enzymes hydrolyse cyclic nucleotides",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "plays important roles in cellular functions",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "INTERACTS_WITH",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "bidirectional": true
      },
      "confidence": 0.8,
      "evidence": "PDEs interact with myomegalin",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E17",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "play crucial role in cardiac contractility",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E18",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "involved in cytoskeletal assembly and disassembly",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "deleterious effects of increased expression of PDE4",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "involved in inflammatory diseases like chronic obstructive pulmonary disease",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "involved in inflammatory diseases like ... asthma",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "overexpression of PDE4 is recorded in cancer",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E11",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "overexpression of PDE4 is recorded in ... retinal degeneration",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E12",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "overexpression of PDE4 is recorded in ... acrodysostosis",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E13",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "overexpression of PDE4 is recorded in ... Alzheimer's disease",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E14",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "overexpression of PDE4 is recorded in ... stroke",
      "source_chunk_ids": [
        "fa95baed12fe3452dade3f428f128a16"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4B inhibitor (Roflumilast",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4B inhibitor (Roflumilast and Apremilast)",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "for COPD (17)",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "psoriasis treatment",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "These inhibitors suppress TNF\u03b1, IL-17, IL-23 expression",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "up-regulate the anti-inflammatory gene IL-10",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "These inhibitors suppress TNF\u03b1, IL-17, IL-23 expression",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "up-regulate the anti-inflammatory gene IL-10",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "potential target in the treatment of neurological disorders",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "potential target in the treatment of neurological disorders",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "potential target in the treatment of neurological disorders",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "potential target in the treatment of neurological disorders",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R13",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E14",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "potential target in the treatment of neurological disorders",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R14",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E15",
      "attributes": {
        "context": "clinical",
        "severity": "dose limiting"
      },
      "confidence": 0.7,
      "evidence": "dose limiting side effects such as nausea",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E16",
      "attributes": {
        "context": "clinical",
        "severity": "dose limiting"
      },
      "confidence": 0.7,
      "evidence": "dose limiting side effects such as vomiting",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E17",
      "attributes": {
        "context": "clinical",
        "severity": "dose limiting"
      },
      "confidence": 0.7,
      "evidence": "dose limiting side effects such as gastric acidity",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "CAUSES",
      "source_entity_id": "E5",
      "target_entity_id": "E15",
      "attributes": {
        "context": "clinical",
        "severity": "dose limiting"
      },
      "confidence": 0.7,
      "evidence": "dose limiting side effects such as nausea",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "CAUSES",
      "source_entity_id": "E5",
      "target_entity_id": "E16",
      "attributes": {
        "context": "clinical",
        "severity": "dose limiting"
      },
      "confidence": 0.7,
      "evidence": "dose limiting side effects such as vomiting",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "CAUSES",
      "source_entity_id": "E5",
      "target_entity_id": "E17",
      "attributes": {
        "context": "clinical",
        "severity": "dose limiting"
      },
      "confidence": 0.7,
      "evidence": "dose limiting side effects such as gastric acidity",
      "source_chunk_ids": [
        "3d05c3d85ffa6cd2b7bcd6e8017f2e0a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE5 inhibitors have serious side effects like non-arteritic anterior ischemic optic neuropathy",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE5 inhibitors have serious side effects like hearing loss",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE7 inhibitors have serious side effects like non-arteritic anterior ischemic optic neuropathy",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE7 inhibitors have serious side effects like hearing loss",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE5 inhibitors exert undesirable effects including tachycardia",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE5 inhibitors exert undesirable effects including reduced peripheral blood pressure",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE7 inhibitors exert undesirable effects including tachycardia",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE7 inhibitors exert undesirable effects including reduced peripheral blood pressure",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "HAS_CLASS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 allosteric modulators -GSK256066",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_CLASS",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 allosteric modulators -GEBR-7b",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_CLASS",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 allosteric modulators -D159687",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_CLASS",
      "source_entity_id": "E11",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 allosteric modulators -D159797",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "HAS_CLASS",
      "source_entity_id": "E12",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 allosteric modulators -TAK-648",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4 allosteric modulators have shown improved blood brain barrier penetrability",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E14",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4 allosteric modulators have shown high potency",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E15",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4 allosteric modulators have shown low side effects",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R17",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E16",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 allosteric modulators have improved efficacy in inflammatory diseases",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E17",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 allosteric modulators have improved efficacy in diabetes",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E18",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 allosteric modulators have improved efficacy in autoimmune disorders",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E19",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 allosteric modulators have improved efficacy in neurological disorders",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R21",
      "type": "ACTS_ON",
      "source_entity_id": "E21",
      "target_entity_id": "E20",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors",
      "source_chunk_ids": [
        "0b10f873584b442da22977ca0cfa6044"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "phosphoinositide-3-kinase results in inhibition of PDE4",
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E18",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ERK results in inhibition of PDE4",
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "UCR1 phosphorylates PKA dependent enzyme activation",
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "metal ions stabilize the protein structure",
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "metal ions stabilize the protein structure",
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "metal ions stabilize the protein structure",
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "metal ions stabilize the protein structure",
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "metal ions stabilize the protein structure",
      "source_chunk_ids": [
        "6f9609e27b9835792db524d5a909678b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "promotes progression"
      },
      "confidence": 0.8,
      "evidence": "PDE4 overexpression promotes ... AD",
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "context": "promotes progression"
      },
      "confidence": 0.8,
      "evidence": "PDE4 overexpression promotes ... PD",
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "promotes progression"
      },
      "confidence": 0.8,
      "evidence": "PDE4 overexpression promotes ... MS",
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "promotes progression"
      },
      "confidence": 0.8,
      "evidence": "PDE4 overexpression promotes ... ALS",
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "promotes progression"
      },
      "confidence": 0.8,
      "evidence": "PDE4 overexpression promotes ... glioma",
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "context": "promotes progression"
      },
      "confidence": 0.8,
      "evidence": "PDE4 overexpression promotes ... stroke",
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "promotes progression"
      },
      "confidence": 0.8,
      "evidence": "PDE4 overexpression promotes ... depression",
      "source_chunk_ids": [
        "1d90b2b65a69eea3869c746bdaaff431"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cAMP play a significant role in long term potentiation",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cAMP play a significant role in synaptic plasticity",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cAMP activates protein kinase A",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "protein kinase A controls the transcription of BDNF",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "BDNF has a pivotal role in cognitive functions",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE inhibitors enhance cAMP signalling and CREB phosphorylation",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Mutations in CREB causes cognitive dysfunction",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Mutations in CREB causes mood disorders",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "mutated form of CBP exhibit developmental aberrations like mental retardation",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mouse models also suffer from memory dysfunction",
      "source_chunk_ids": [
        "081c234d778d09feab44ae64ea3aa23e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Rolipram is reported to improve long-term memory",
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "instigates"
      },
      "confidence": 0.75,
      "evidence": "CREB signalling instigated",
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "instigates"
      },
      "confidence": 0.7,
      "evidence": "instigated by CBP mutations",
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "promotes neurogenesis",
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "action": "promotes"
      },
      "confidence": 0.75,
      "evidence": "neurogenesis in the hippocampal region",
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "enhances the neuronal survival",
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.75,
      "evidence": "enhances the neuronal survival via cAMP/CREB signalling",
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "INTERACTS_WITH",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "bidirectional": true,
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Rolipram administered with imipramine",
      "source_chunk_ids": [
        "27f9e122d0f6d0d923d41853936eb1d1"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Activation of cAMP/CREB/BDNF signalling exerts antidepressant-like effects",
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "RACK1, called as GNB2L1",
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "RACK1 interacts (inhibits) with PDE4D5",
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "RACK1 stimulates cAMP/PKA pathway",
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "involvement in memory functions",
      "source_chunk_ids": [
        "00531eba42957715ceac19ee93480b74"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "NO is a soluble gas formed by nitric oxide synthase",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "sGC is responsible for cGMP synthesis and activation of PKG",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PKG leads to activation important for memory formation",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "impedes"
      },
      "confidence": 0.7,
      "evidence": "Phosphodiesterase enzymes impede the signal transduction",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "NMDA receptors activates NO synthase",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E6",
      "target_entity_id": "E13",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "PDE2 inhibitor improves memory consolidation in memory deficits",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "PDE5 inhibitors increase cognitive performance",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E8",
      "target_entity_id": "E14",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "Inhibition of PDE4 elicited anxiolytic effects",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Preclinical studies have shown",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "Preclinical studies have shown that PDE5 inhibitors",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "PDE5 inhibitors increase cognitive performance",
      "source_chunk_ids": [
        "83f116a34993542199ed02353434ec68"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "influences"
      },
      "confidence": 0.85,
      "evidence": "PDE enzymes influence NO/cGMP/PKG pathway",
      "source_chunk_ids": [
        "052100099747fa98b3d9e363d741640b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "elicits beneficial effects in brain disorders",
      "source_chunk_ids": [
        "052100099747fa98b3d9e363d741640b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "mechanistic"
      },
      "confidence": 0.7,
      "evidence": "elicits beneficial effects in brain disorders",
      "source_chunk_ids": [
        "052100099747fa98b3d9e363d741640b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.8,
      "evidence": "Activation of ERK signalling enhances LTP",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "interacts with"
      },
      "confidence": 0.75,
      "evidence": "PKA and MAPK/ ERK are found to interact",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "MAPK pathway activates CREB",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibition by rolipram",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.75,
      "evidence": "rolipram is reported to block MAPK signalling",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Inhibition of MAPK/ ERK signalling is found to produce cognitive deficits",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.7,
      "evidence": "reduce hippocampal synaptic plasticity",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "reverses"
      },
      "confidence": 0.75,
      "evidence": "rolipram reverses ERK inhibition induced memory deficits",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {
        "action": "causes"
      },
      "confidence": 0.7,
      "evidence": "rolipram potentially trigger... causes phosphorylation of CREB",
      "source_chunk_ids": [
        "966359f6515cd39ee182aff7c18c939f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "regulates"
      },
      "confidence": 0.85,
      "evidence": "regulates the transcription of BDNF",
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "plays a vital role in"
      },
      "confidence": 0.8,
      "evidence": "plays a vital role in the maintenance of hippocampal LTP",
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "action": "accelerates"
      },
      "confidence": 0.75,
      "evidence": "Upregulation of BDNF also accelerates neurogenesis",
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "action": "accelerates"
      },
      "confidence": 0.75,
      "evidence": "accelerates synaptic plasticity",
      "source_chunk_ids": [
        "3facd091c27eb5ae1eeefd61294e1ca5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4 isoforms are shown to inhibit neuroplasticity",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PDE4A5 is shown to reduce LTP and dendritic spine number",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {
        "assertion": "refutes"
      },
      "confidence": 0.8,
      "evidence": "PDE4A knockout mice show neuronal cell proliferation",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibition is shown to improve hippocampal LTP",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E21",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Rolipram is shown enhance neural progenitor cell production",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E14",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.75,
      "evidence": "Inhibition of proinflammatory cytokines release by PDE4I",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Mutation in PDE4 reduce IL-1\u03b2, TNF-\u03b1, NF-\u03baB levels",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Mutation in PDE4 increase pCREB and BDNF expression",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E22",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "FFPM exerts activation of PKA, BDNF and CREB phosphorylation",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E22",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "FFPM reduced NF-\u03baB, TNF-\u03b1 and IL-1\u03b2 levels",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E23",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Roflumilast prevents deficits in synaptic plasticity",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E23",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Roflumilast increases AMPA-GluR1 and PSD-95 expression",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E20",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibition with Rolipram facilitates synaptic plasticity",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "ACTS_ON",
      "source_entity_id": "E21",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibition with Rolipram",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E22",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "FFPM, a PDE4 inhibitor",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "ACTS_ON",
      "source_entity_id": "E23",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "Roflumilast prevents deficits",
      "source_chunk_ids": [
        "bc7fb84216d5cfc90d6211eb74d8ef86"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits",
        "context": "potential therapeutic"
      },
      "confidence": 0.7,
      "evidence": "inhibition of PDE4 appear as potential target in the treatment of neurological disorders",
      "source_chunk_ids": [
        "4922697b78bd2aaaaf865b2f77d6c12b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4D by D159687 and D159797, two allosteric PDE4D inhibitors",
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4D by D159687 and D159797, two allosteric PDE4D inhibitors",
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "has been shown to improve the retrieval process",
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "PDE4D by D159687 and D159797",
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "PDE4D by D159687 and D159797",
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "female Cynomolgus Monkeys",
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "context": "potential"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors might be beneficial in AD treatment",
      "source_chunk_ids": [
        "2deb99e8f436bfc3a087855d9b4a170a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "FCPR16, a PDE4 inhibitor",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "XT-44, a PDE4 inhibitor",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "rolipram treatment improves dopamine",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mediated by cAMP/PKA/CREB pathway",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "via AMPK pathway",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mediated via cAMP/PKA/CREB pathway",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mediated via cAMP/PKA signalling",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "context": "pre-clinical and clinical"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors appear to be promising drugs in the treatment of PD",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "rolipram treatment improves dopamine and alleviates Parkinsonism",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [
        "E8"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "double-blind trial",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "rolipram treatment improves dopamine",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "improves the level of dopamine",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "alleviates the severity of Parkinsonism",
      "source_chunk_ids": [
        "8cdcbbe442d9a996759e8c523ab69f58"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "ibudilast ... protect the astrocytes",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "inhibiting the release of cytochrome c",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "caspase-3 activation",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "nuclear condensation",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE inhibition",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "increase in cGMP levels through PDE inhibition",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "linked to the observed protection",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "context": "potential"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibition can be a potential option the management of PD",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "(142)",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E11",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.7,
      "evidence": "ibudilast ... is reported",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "protect the astrocytes",
      "source_chunk_ids": [
        "768c84804a5e0e7b2b7236c3fdb8c96c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Decreased levels of cAMP are linked to demyelination",
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cAMP analogues are reported to reduce inflammation",
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Dibutyryl cyclic AMP performs myelin repair",
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibition suppresses the immune response",
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibition increases remyelination",
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.7,
      "evidence": "performs myelin repair in MS",
      "source_chunk_ids": [
        "dddd9896f3d1d18a232a6a209ace9145"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "decreases"
      },
      "confidence": 0.85,
      "evidence": "decreases TNF-\u03b1 levels",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "decreases TNF-\u03b1 levels",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "increasing the expression of MAPK phosphatase-1",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibiting NF-\u03baB complexes",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "inhibiting NF-\u03baB complexes",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibition with rolipram",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "reduced inflammation",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "demyelination",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "delayed onset of clinical signs",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.7,
      "evidence": "reduced inflammation",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "context": "experimental",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "demyelination",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "experimental",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "delayed onset of clinical signs",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R13",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "context": "experimental",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "EAE rodent model of MS",
      "source_chunk_ids": [
        "537e872a6aeb1e3655e2810f43b23498"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "BBB022, a PDE4 inhibitor",
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "decreases the severity of EAE",
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "stabilizes the blood brain barrier",
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "decreases the severity of EAE",
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "context": "preclinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "EAE induced MS",
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "investigating the efficacy of PDE4 inhibitors",
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Clinical trials are underway",
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "potential treatment",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "potential of PDE4 inhibition in MS treatment",
      "source_chunk_ids": [
        "4f9419d8b3337c64f2c1bd2d32ccc77a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "DISC1-mutant mice with impaired affinity to PDE4B exhibit either schizophrenia",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Animal studies have given ample evidences",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.75,
      "evidence": "DISC1-mutant mice with impaired affinity to PDE4B",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors like rolipram",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors like roflumilast",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "possess antipsychotic-like properties",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [
        "E5"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "improves verbal learning in schizophrenic patients",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors like rolipram possess antipsychotic-like properties",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors like roflumilast possess antipsychotic-like properties",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Roflumilast improves verbal learning",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "reduce methamphetamine-induced hyper-locomotion",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "reverses amphetamine-disrupted auditory sensory processing",
      "source_chunk_ids": [
        "15ddd53d356c0e902e4e90431ce5ebd1"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "dysfunction of cAMP signalling in depressive patients",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "\u03b21 and \u03b22- adrenergic receptors produce anti-depressant like effects",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "\u03b21 and \u03b22- adrenergic receptors produce anti-depressant like effects",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "stimulates"
      },
      "confidence": 0.75,
      "evidence": "increase the formation of cAMP through adenylyl cyclase stimulation",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "stimulates"
      },
      "confidence": 0.75,
      "evidence": "increase the formation of cAMP through adenylyl cyclase stimulation",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Zhang et al., (2005) demonstrated that PDE4 inhibition",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibition produced an \u201cadditive\u201d anti-depressant effect",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "anti-depressant effect when administered along with dobutamine",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "synergistic was observed when administered clenbuterol",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E3",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "dobutamine, \u03b21 agonist",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E12",
      "target_entity_id": "E4",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "clenbuterol, \u03b22- agonist",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "context": "research"
      },
      "confidence": 0.75,
      "evidence": "PDE4 inhibition produced an \u201cadditive\u201d anti-depressant effect",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [
        "E9"
      ],
      "verified": true
    },
    {
      "id": "R13",
      "type": "ACTS_ON",
      "source_entity_id": "E16",
      "target_entity_id": "E6",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "rolipram, produced showed significant behavioural improvement",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "TREATS",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "significant behavioural improvement in major depressive disorder patients",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E18",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "significant behavioural improvement in major depressive disorder patients",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E19",
      "attributes": {
        "context": "research",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "involvement of cardiovascular risks hinders clinical investigation",
      "source_chunk_ids": [
        "e755673647c4021c3ebeb2e2621eb959"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "decrease in cAMP levels in living depressive patients",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.75,
      "evidence": "decrease in cAMP levels in living depressive patients",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Fujita et al (2017) provide evidence",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "Inhibition of PDE4 increases the level of cAMP",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "increases the level of cAMP, pCREB",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "promote hippocampal neurogenesis",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "corroborated to antidepressant-like effect",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "potential",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4 inhibitors in depression",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Clinical trials are underway",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "PDE4 inhibitors in depression",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "under investigation",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "efficacy of PDE4 inhibitors in depression",
      "source_chunk_ids": [
        "8fde9d5fae924be1cd4870767e865a5c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "context": "pathological"
      },
      "confidence": 0.8,
      "evidence": "causes increased cellular toxicity",
      "source_chunk_ids": [
        "a0f5122054e92f36655191105a73ed2c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "context": "pathological"
      },
      "confidence": 0.75,
      "evidence": "generates inclusion bodies (IBs)",
      "source_chunk_ids": [
        "a0f5122054e92f36655191105a73ed2c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors",
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "rolipram is shown to increase the phosphorylation of CREB and BDNF",
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "improves the clinical signs in rodent model of HD",
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors reduce cortical and striatal neuronal degeneration",
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "potential drugs to treat HD",
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "supporting_study_ids": [
        "E9"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "clinical trial",
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "efficacy of rolipram in HD",
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "efficacy"
      },
      "confidence": 0.7,
      "evidence": "determine the efficacy of rolipram in HD",
      "source_chunk_ids": [
        "28baf94997a42f317f2af205b495ebad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "Rolipram restores endothelial function in stroke",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Rolipram restores endothelial function",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Rolipram increases hippocampal neurogenesis",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "decreases ischemic injury in neuronal cultures",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.8,
      "evidence": "Rolipram restores endothelial function in stroke",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [
        "E15"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.8,
      "evidence": "decreases ischemic injury",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [
        "E15"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "reported a decrease in stroke risk with PDE4 inhibition",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "decrease in stroke risk",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in rat model of cerebral stroke",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Rolipram restores endothelial function",
      "source_chunk_ids": [
        "34f03432785a906ae5de46d54605be55"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "implicated in development",
        "assertion": "suggests"
      },
      "confidence": 0.7,
      "evidence": "PDEs are implicated in the development",
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "role on",
        "assertion": "established"
      },
      "confidence": 0.75,
      "evidence": "role of cAMP on brain tumours",
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "role on development",
        "assertion": "well studied"
      },
      "confidence": 0.8,
      "evidence": "role of cAMP on the development of glioma",
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.7,
      "evidence": "in vitro models",
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.7,
      "evidence": "in vivo models",
      "source_chunk_ids": [
        "dd6cf81784c399013a5b1c67574c1074"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "TBI imposes cognitive deficits",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "TBI increases the expression of PDE4",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4B2 levels increase after TBI",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4D2 is highly expressed after TBI",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "decrease in cAMP levels after TBI",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "decrease in cAMP triggers release of proinflammatory mediators",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "decrease in cAMP affects LTP",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "leads to cognitive decline",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "Rolipram reduces expression",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Rolipram reduces expression of inflammatory mediators",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "inflammatory mediators like TNF-\u03b1",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "inflammatory mediators like IL-1\u03b2",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Rolipram improves cognitive function",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Rolipram prevents neuronal loss",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E2",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.75,
      "evidence": "improves cognitive function",
      "source_chunk_ids": [
        "9901ee931a6a8fa35deca4dd0f06030b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.9,
      "evidence": "rolipram modulates PDE4 isoforms",
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "It also reduces the deposition of the beta-amyloid precursor protein",
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "rolipram modulates PDE4 isoforms",
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "can effectively manage TBI symptoms",
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "context": "suggested"
      },
      "confidence": 0.75,
      "evidence": "can effectively manage TBI symptoms",
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "PDE4 is a potential target in the management of TBI",
      "source_chunk_ids": [
        "4580a84e04ff329e3b98b14ac3f177ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "Rolipram is shown",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "administration of roflumilast",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "Betulinic acid, a naturally occurring PDE4 inhibitor",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "alpha-mangostin, a natural PDE4 inhibitor",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Inhibition of PDE4 results in the increase in cAMP level",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Increased levels of cAMP are reported to dilate pial vessels",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "improves memory functions",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "context": "mechanistic"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibition improves blood flow to the brain in VD",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Liang et al. (2020) reported",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "alpha-mangostin, a natural PDE4 inhibitor",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "improves memory functions",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "does not cause emesis behaviour",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "CAUSES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {
        "context": "clinical",
        "assertion": "refutes",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "does not cause emesis behaviour",
      "source_chunk_ids": [
        "3f8c88676c77fc27f9b920f90638e504"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": false
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors in the treatment of AD",
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors in the treatment of PD",
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors in the treatment of MS",
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors in the treatment of HD",
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors in the treatment of stroke",
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors in the treatment of depression",
      "source_chunk_ids": [
        "fa5f6ea5e3cbb819003c651e6646edb7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "Rolipram, a cAMP specific PDE4 inhibitor",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "clinical trial with rolipram",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "clinical trial with rolipram",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "showed potent antidepressant activity",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "showed potent antidepressant activity",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [
        "E5"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "produced dose dependent side effects like emesis",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "produced dose dependent side effects like headache",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "increased gastric secretion",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "context": "clinical",
        "severity": "dose dependent"
      },
      "confidence": 0.7,
      "evidence": "produced dose dependent side effects like emesis",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [
        "E5"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "context": "clinical",
        "severity": "dose dependent"
      },
      "confidence": 0.7,
      "evidence": "produced dose dependent side effects like headache",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [
        "E5"
      ],
      "verified": true
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "severity": "dose dependent",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "increased gastric secretion",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [
        "E5"
      ],
      "verified": false
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "rolipram inhibits both PDE4B and PDE4D",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "clinical trial to re-evaluate",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "clinical trial to re-evaluate the antidepressant activity of rolipram",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "has a potent antidepressant activity",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "has a potent antidepressant activity",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [
        "E12"
      ],
      "verified": true
    },
    {
      "id": "R17",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E14",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "rolipram inhibits both PDE4B and PDE4D",
      "source_chunk_ids": [
        "ecf112e74bd516c4d926d6025b70c4af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "first generation PDE4 inhibitors such as roflumilast",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "first generation PDE4 inhibitors such as rolipram",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "first generation PDE4 inhibitors such as apremilast",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "first generation PDE4 inhibitors such as RS25344",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "first generation PDE4 inhibitors such as PMNPQ",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "therapeutic effect in clinical trials",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "therapeutic effect in clinical trials",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "therapeutic effect in clinical trials",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "side effects like nausea",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "emesis",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "gastric hypersecretion",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "Cilomilast, a second generation PDE4 inhibitor",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "CAUSES",
      "source_entity_id": "E11",
      "target_entity_id": "E9",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "still shows emesis",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "non-specific inhibitors of all four subtypes",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E12",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "non-specific inhibitors of all four subtypes",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E12",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "non-specific inhibitors of all four subtypes",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E12",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "non-specific inhibitors of all four subtypes",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "non-specific inhibitors of all four subtypes",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "non-specific inhibitors of all four subtypes",
      "source_chunk_ids": [
        "4c349c1a58f6cfe259b3f890048ce083"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "modulates",
        "context": "knockout mice study"
      },
      "confidence": 0.8,
      "evidence": "PDE4D isoform is responsible for emesis",
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "PDE4D could potentially modulates the alpha_2-adrenoceptor",
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "context": "potential mechanism",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "causes emesis",
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "potential mechanism",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "causes emesis and other side effects",
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "knockout mice study"
      },
      "confidence": 0.7,
      "evidence": "PDE4D-deficient mice show an amplified sympathetic drive",
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "knockout mice study"
      },
      "confidence": 0.7,
      "evidence": "decrease in sleeping time under xylazine/ketamine-induced anaesthesia",
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "identified"
      },
      "confidence": 0.75,
      "evidence": "Studies in knockout mice have shown that PDE4D isoform is responsible",
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "identified"
      },
      "confidence": 0.7,
      "evidence": "X-ray crystallography techniques have helped in identifying",
      "source_chunk_ids": [
        "234c297289d807cc1550bf85599a8afb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "negative allosteric modulator"
      },
      "confidence": 0.85,
      "evidence": "D159687, a negative allosteric modulator of PDE4D",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "enhances learning and memory in TBI rats",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "enhances learning and memory in TBI rats",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "action": "does not induce",
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "does not induce emesis",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "action": "allosteric modulator"
      },
      "confidence": 0.85,
      "evidence": "D159797 is a UCR2-directed allosteric modulator of PDE4D",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {
        "action": "reduces",
        "measurement": {
          "value": 300,
          "unit": "fold",
          "measurement_type": "relative_potential",
          "notes": "less emetic potential compared to rolipram"
        }
      },
      "confidence": 0.8,
      "evidence": "300 fold less emetic potential",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "improving synaptic plasticity",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "increasing the spine density",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "upregulating the expression of neurotrophic factors",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "clinical utility of PDE4 inhibitors in neurological disorders",
      "source_chunk_ids": [
        "eae43d21200efa35c8821464b9ca78ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.8,
      "evidence": "Inhibition of PDE4 is shown to improve cAMP levels",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.85,
      "evidence": "Inhibition of PDE4 is shown to offer neuroprotective effects",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "neuroprotective effects in AD",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "neuroprotective effects in PD",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "neuroprotective effects in HD",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "neuroprotective effects in depression",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "neuroprotective effects in MS",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "neuroprotective effects in epilepsy",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "neuroprotective effects in schizophrenia",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "non-specific PDE4 inhibitors produce side effect",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E4",
      "attributes": {
        "context": "preclinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4B inhibitors have shown therapeutic properties",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E12",
      "target_entity_id": "E4",
      "attributes": {
        "context": "preclinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4D inhibitors have shown therapeutic properties",
      "source_chunk_ids": [
        "137bf237900902013e6df2a07df9884d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Phosphodiesterase inhibitors. Br J Pharmacol. (2006)",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Cyclic nucleotide phosphodiesterase (PDE) superfamily",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Myomegalin is a novel A-kinase anchoring protein",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Myomegalin is a novel A-kinase anchoring protein",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "phosphorylation of cardiac myosin binding protein C",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Myomegalin is a novel protein of the golgi/centrosome",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Myomegalin is a novel protein of the golgi/centrosome",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "interacts with a cyclic nucleotide phosphodiesterase",
      "source_chunk_ids": [
        "4cd03df115f7fa4367ec1bb7b2b4de5f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.9,
      "evidence": "Induces Headache in Healthy Subjects",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "targets"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase 4-targeted treatments for autoimmune diseases",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibitor of phosphodiesterase 4",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "GSK256066, an exceptionally high-affinity and selective inhibitor",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "Anti-inflammatory PDE4 Inhibitor",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "PDE4 Inhibitor TAK-648",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "studies"
      },
      "confidence": 0.8,
      "evidence": "TAK-648 in Type 2 Diabetes",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E13",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "Apremilast: a novel PDE4 inhibitor",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "treatment of autoimmune and inflammatory diseases",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [
        "E12"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Apremilast: a novel PDE4 inhibitor",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E4",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "Phosphodiesterase Inhibitors as a Therapeutic Approach",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E16",
      "target_entity_id": "E4",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "Phosphodiesterase Inhibitors as Therapeutics",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {
        "outcome": "targets"
      },
      "confidence": 0.85,
      "evidence": "Therapeutics for Traumatic Brain Injury",
      "source_chunk_ids": [
        "cc9c1fc0a1773fec0f263a3b24502d22"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "phosphodiesterase-4 as a therapeutic target",
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "activate cAMP phosphodiesterase-4D3 (PDE4D3)",
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cGMP-specific phosphodiesterase",
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "target for the development of antidepressant drugs",
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Cyclic AMP-specific phosphodiesterase-4 as a target",
      "source_chunk_ids": [
        "724a4c577b0545f36f94de00c72f9349"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "cAMP/CREB signaling system",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cognition enhancement",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.8,
      "evidence": "ameliorates cognitive deficits",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [
        "E6"
      ],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "in situ hybridization histochemistry",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "Phosphodiesterase-4 inhibitors",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "ameliorates cognitive deficits",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "review",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "Selective phosphodiesterase inhibitors",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "suggests"
      },
      "confidence": 0.8,
      "evidence": "cognition enhancement",
      "source_chunk_ids": [
        "2e0f0960a50a1435cc03310a1ed0cd6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "MAP kinase ERK2",
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "phosphodiesterase HSPDE4D3",
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "phospho-MAP kinase",
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "RSK family of kinases",
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Activated CREB",
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4",
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "phosphodiesterase inhibitor rolipram",
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Mitogen-activated protein kinase-mediated",
      "source_chunk_ids": [
        "c3295a3553d48d0a1531bd39b967f671"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Alzheimer's disease brains",
      "source_chunk_ids": [
        "e967513a4e1c2d58dc742cbf0fe060c",
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "phosphodiesterase type 7",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "phosphodiesterase type 8",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Alzheimer's disease",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Alzheimer's disease",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Alzheimer's disease",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Alzheimer disease brain",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cAMP-dependent protein kinase",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "over-activated calpain",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "rolipram treatment",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Alzheimer mouse model",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "improvement in synaptic and cognitive functions",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "rolipram treatment",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Alzheimer disease models",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Reversal of long-term dendritic spine alterations",
      "source_chunk_ids": [
        "e967513a4e1c2d5b8dc742cbf0fe060c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Ann Clin Transl Neurol",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.85,
      "evidence": "multiple sclerosis",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "animal model of autoimmune demyelination",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.85,
      "evidence": "autoimmune demyelination",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Neurol Res",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.85,
      "evidence": "relapsing-remitting multiple sclerosis",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "J Neurosci Res",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.85,
      "evidence": "spinal cord injury",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Ann Med",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "J Neurol",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.85,
      "evidence": "multiple sclerosis patients",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E17",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "experimental autoimmune encephalomyelitis",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E17",
      "target_entity_id": "E19",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.85,
      "evidence": "experimental autoimmune encephalomyelitis",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E20",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "EAE in C57BL/6 mice",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E20",
      "target_entity_id": "E19",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.85,
      "evidence": "EAE",
      "source_chunk_ids": [
        "6e2e8c435fb8978445c28a315c5903ca"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "rats",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "rat brain",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Signaling from beta adrenergic receptors",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "rats",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "depressed patients",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "mice",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "mice",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "beta(1)- and beta(2)-adrenoceptor subtypes",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "beta(1)- and beta(2)-adrenoceptor subtypes",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PDE4",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "antidepressant-like behavioral effects",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "cAMP signaling in brain",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "depressed patients",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "cAMP signaling in brain is decreased",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Phosphodiesterase-4D",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "depressive-like behaviors",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "alleviates depressive-like behaviors",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "alleviates memory deficits",
      "source_chunk_ids": [
        "73f49a1b1ce2e0118048e81e43460475"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Comparison of the Pharmacological Profiles",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "Selective PDE4B and PDE4D Inhibitors",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "Selective PDE4B and PDE4D Inhibitors",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "promotes survival of newborn hippocampal neurons after ischemia",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase inhibitor rolipram",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "context"
      },
      "confidence": 0.85,
      "evidence": "after ischemia",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "promotes survival of newborn hippocampal neurons",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.75,
      "evidence": "promotes survival of newborn hippocampal neurons after ischemia",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [
        "E5"
      ],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "promotes survival of newborn hippocampal neurons",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "R6/2 mouse model of Huntington's disease",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Beneficial effects of rolipram",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "context"
      },
      "confidence": 0.9,
      "evidence": "mouse model of Huntington's disease",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "Beneficial effects of rolipram",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.75,
      "evidence": "Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Beneficial effects of rolipram",
      "source_chunk_ids": [
        "b852971aa7625dfc5b69da9858eac89f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "blood-brain-barrier damage",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "inflammation",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "thrombosis",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "amyotrophic lateral sclerosis",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "mutation in VAPB",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "TDP-43 mutations",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Kynurenine pathway metabolism",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "quinolinic acid",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Glial Cells",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E20",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ibudilast",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E20",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "clearance of SOD1",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E20",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "TFEB-mediated autophagy",
      "source_chunk_ids": [
        "b7236bb76345438dd4792b6598ac9a15"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Rolipram potentiates",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.8,
      "evidence": "glioblastoma stem-like cells",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "potentiates"
      },
      "confidence": 0.75,
      "evidence": "potentiates bevacizumab-induced cell death",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "glioblastoma multiforme",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vivo",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibits brain tumor growth",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vivo",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "traumatic brain injury",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "rescues"
      },
      "confidence": 0.8,
      "evidence": "rescues chronic cognitive deficits",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vivo",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E18",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.8,
      "evidence": "defects in memory function",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E19",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E19",
      "target_entity_id": "E21",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.8,
      "evidence": "CNS injury",
      "source_chunk_ids": [
        "6c1f0623d3965a6a55dcdc68bd877692"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Design of phosphodiesterase 4D (PDE4D) allosteric modulators",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4D (PDE4D) allosteric modulators",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Deletion of phosphodiesterase 4D in mice",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4D",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "correlates"
      },
      "confidence": 0.8,
      "evidence": "behavioral correlate of emesis",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "enhances learning after traumatic brain injury",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "negative allosteric modulator of PDE4D",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "after traumatic brain injury",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in Female Cynomolgus Monkeys",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "Selective PDE4D Negative Allosteric Modulators",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E14",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in humanized PDE4D mice",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E14",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "selective phosphodiesterase 4D inhibitor BPN14770",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "reverses"
      },
      "confidence": 0.8,
      "evidence": "reverses beta amyloid-induced memory impairment",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E17",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "with anti-inflammatory activities",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "STUDIES",
      "source_entity_id": "E17",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "novel phosphodiesterase 4 inhibitor",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E17",
      "target_entity_id": "E19",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "anti-inflammatory activities",
      "source_chunk_ids": [
        "5b5bcb766e8d9433fec073a2ba536367"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.85,
      "evidence": "alcohol-induced steatosis",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.85,
      "evidence": "kidney fibrosis",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "Inhibition of PDE4B",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "targets"
      },
      "confidence": 0.85,
      "evidence": "neuroinflammation",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.85,
      "evidence": "allergic asthma",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "contributes"
      },
      "confidence": 0.85,
      "evidence": "prostate cancer",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in vitro",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in mice",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in mice",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "PDE4B",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "PDE4B",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "PDE4B",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "PDE4B",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "STUDIES",
      "source_entity_id": "E11",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "PDE4B",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "PDE4B",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E15",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "CP-80,633",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "elevates"
      },
      "confidence": 0.85,
      "evidence": "elevates plasma cyclic AMP levels",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E17",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.85,
      "evidence": "decreases tumor necrosis factor-alpha (TNFalpha) production",
      "source_chunk_ids": [
        "1b5eb0ed6add5dacf33014949e44405d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "The FASEB Journal",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase 4",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "reduces skeletal muscle protein catabolism",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Biochem Biophys Res Commun",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "Pde4d",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Biol Reprod",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "PDE4D Isoforms",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "FEBS Letters",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "Reduced PDE4 expression and activity",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "enhanced catecholamine-induced cAMP accumulation",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PNAS",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E6",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "phosphodiesterase subtype 4D",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "human cancers",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Clin Cancer Res",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E6",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "PDE4D Inhibition",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "overcoming Tamoxifen Resistance",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E14",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Biochem J",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "STUDIES",
      "source_entity_id": "E14",
      "target_entity_id": "E6",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "PDE4D",
      "source_chunk_ids": [
        "1d187a0e874e27e3be20cc51dea4127c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "structural"
      },
      "confidence": 0.75,
      "evidence": "Long isoform additionally includes a green UCR1 domain",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "structural"
      },
      "confidence": 0.75,
      "evidence": "Long isoform: UCR2",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "structural"
      },
      "confidence": 0.75,
      "evidence": "Long isoform: Catalytic unit",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "context": "structural"
      },
      "confidence": 0.75,
      "evidence": "Short isoform: UCR2",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "context": "structural"
      },
      "confidence": 0.75,
      "evidence": "Short isoform: Catalytic unit",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "structural"
      },
      "confidence": 0.75,
      "evidence": "Super short isoform: UCR2",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "context": "structural"
      },
      "confidence": 0.75,
      "evidence": "Super short isoform: Catalytic unit",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "context": "regulatory"
      },
      "confidence": 0.7,
      "evidence": "PKA phosphorylation site is located on the UCR1 domain",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E10",
      "attributes": {
        "context": "regulatory"
      },
      "confidence": 0.7,
      "evidence": "ERK phosphorylation site is located on the catalytic unit",
      "source_chunk_ids": [
        "a426b28159afd45a211680f0b9eb0ca7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Cedervall et al., 2015",
      "source_chunk_ids": [
        "bf484e0f0258178462ab6c227c7916c2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "MPP+ inhibits the cAMP/PKA/CREB",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "MPP+ inhibits the Epac/Akt",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "leads to a decrease in mitochondrial membrane potential",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "leads to an increase in reactive oxygen species",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "leading to neurodegeneration",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "These changes result in neurodegeneration",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "These changes result in neurodegeneration",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "action": "increases"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors act by increasing cAMP",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activates the cAMP/PKA/CREB pathway",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activates the Epac/Akt pathway",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "TREATS",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {
        "context": "mechanistic"
      },
      "confidence": 0.8,
      "evidence": "preventing neurodegeneration",
      "source_chunk_ids": [
        "ef1db9e1452db3391706c27965f394a9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "MPP+ triggers the accumulation of reactive oxygen species",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "MPP+ reduces mitochondrial membrane potential",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "increase in expression of Bax",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "decrease in the level of Bcl-2",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "leads to neurodegeneration",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "MPP+ inhibits cAMP/PKA/CREB signalling pathway",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "MPP+ inhibits Epac/Akt signalling pathway",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors act by increasing the level of cAMP",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "activates cAMP/PKA/CREB and Epac/Akt signalling pathways",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "prevents neurodegeneration",
      "source_chunk_ids": [
        "fbc6ce5af5a33f2183c0d5c69bc2b5f2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.85,
      "evidence": "Activation of the GPCR leads to the activation of the Gs subunit",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "leads to the activation of the Gs subunit and Adenylate Cyclase",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "produces"
      },
      "confidence": 0.9,
      "evidence": "AC catalyzes the conversion of ATP to cAMP",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.9,
      "evidence": "cAMP activates two main pathways: Protein Kinase A (PKA)",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.9,
      "evidence": "cAMP activates two main pathways: ... Epac",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.9,
      "evidence": "PKA activates CREB",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.9,
      "evidence": "CREB then activates BDNF",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "BDNF promotes ... Neurogenesis",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "BDNF promotes ... Neuroplasticity",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E11",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.9,
      "evidence": "Epac activates ERK1/2",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E7",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "ERK1/2 inhibits CREB",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {
        "action": "promotes"
      },
      "confidence": 0.85,
      "evidence": "ERK1/2 ... promotes IL-1\u03b2",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "ACTS_ON",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "action": "increases expression"
      },
      "confidence": 0.8,
      "evidence": "Stroke conditions lead to increased PDE4 expression",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "ACTS_ON",
      "source_entity_id": "E14",
      "target_entity_id": "E4",
      "attributes": {
        "action": "degrades"
      },
      "confidence": 0.9,
      "evidence": "PDE4 degrades cAMP",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E15",
      "target_entity_id": "E14",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors (PDE4I) can counteract this effect",
      "source_chunk_ids": [
        "3571dd5b6e5163a0c31faf4466384768"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activates G\\alpha subunit",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activates adenylyl cyclase",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "catalyses"
      },
      "confidence": 0.8,
      "evidence": "catalyses the conversion of ATP to cAMP",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "leads to activation of protein kinase A",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "activates exchange proteins activated by cAMP",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.7,
      "evidence": "activates cAMP-responsive element-binding protein",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.7,
      "evidence": "activates cAMP-responsive element-binding protein",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "action": "over expression"
      },
      "confidence": 0.8,
      "evidence": "stroke conditions there is an over expression of PDE4",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "action": "decreases"
      },
      "confidence": 0.8,
      "evidence": "decreases the cAMP levels",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "decreases the cAMP levels which inhibits PKA/CREB",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "decreases the cAMP levels which inhibits Epac/ERK1/2 signalling",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "action": "production"
      },
      "confidence": 0.75,
      "evidence": "critical for the production of neurotrophic factors like BDNF",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E15",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "Epac/ERK1/2 activation inhibits proinflammatory factors",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E4",
      "attributes": {
        "action": "increasing"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors act by increasing the levels of cAMP",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E13",
      "attributes": {
        "action": "increasing"
      },
      "confidence": 0.75,
      "evidence": "increasing the levels of cAMP/BDNF",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {
        "action": "role"
      },
      "confidence": 0.8,
      "evidence": "play a crucial role in neurogenesis",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E18",
      "attributes": {
        "action": "role"
      },
      "confidence": 0.8,
      "evidence": "role in neurogenesis and neuroplasticity",
      "source_chunk_ids": [
        "39fe2fa201d59c8e3cb127ecdb082b4c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "converts"
      },
      "confidence": 0.85,
      "evidence": "Tryptophan is converted to Kynurenine by IDO",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "converts"
      },
      "confidence": 0.85,
      "evidence": "Tryptophan is converted to Kynurenine by TDO",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "action": "converts"
      },
      "confidence": 0.85,
      "evidence": "Kynurenine is converted to Kynurenic acid by KAT",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "action": "converts"
      },
      "confidence": 0.85,
      "evidence": "Kynurenine is converted to Anthranilic acid by KZ",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "action": "converts"
      },
      "confidence": 0.85,
      "evidence": "Kynurenine is converted to 3-Hydroxykynurenine by HK",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E10",
      "attributes": {
        "action": "converts"
      },
      "confidence": 0.85,
      "evidence": "3-Hydroxykynurenine is converted to Quinolinic acid by HAO",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Quinolinic acid leads to Excitotoxicity",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Quinolinic acid leads to Neuroinflammation",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Quinolinic acid leads to Oxidative stress",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Excitotoxicity leads to Motor neuron death",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Neuroinflammation leads to Motor neuron death",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Oxidative stress leads to Motor neuron death",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "ACTS_ON",
      "source_entity_id": "E18",
      "target_entity_id": "E17",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 is inhibited by Ibudilast",
      "source_chunk_ids": [
        "2cfff7d8e40fb82e970988381a396fb3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "action": "increases expression"
      },
      "confidence": 0.8,
      "evidence": "Increase in Quinolinic acid increases PDE4 expression",
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {
        "action": "leads to"
      },
      "confidence": 0.8,
      "evidence": "PDE4 leads to excitotoxicity",
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {
        "action": "leads to"
      },
      "confidence": 0.8,
      "evidence": "PDE4 leads to neuroinflammation",
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E14",
      "attributes": {
        "action": "leads to"
      },
      "confidence": 0.8,
      "evidence": "PDE4 leads to oxidative stress",
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E16",
      "attributes": {
        "action": "contributes to"
      },
      "confidence": 0.7,
      "evidence": "excitotoxicity leads to neuronal loss",
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E16",
      "attributes": {
        "action": "contributes to"
      },
      "confidence": 0.7,
      "evidence": "neuroinflammation leads to neuronal loss",
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E16",
      "attributes": {
        "action": "contributes to"
      },
      "confidence": 0.7,
      "evidence": "oxidative stress leads to neuronal loss",
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E16",
      "target_entity_id": "E15",
      "attributes": {
        "context": "pathological"
      },
      "confidence": 0.75,
      "evidence": "neuronal loss in ALS",
      "source_chunk_ids": [
        "671305b2c0ade4a3eec4b524b2f7725e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: GSK356278",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: Rolipram",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "Huntington Disease",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: BPN14770",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "Alzheimer Disease",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: Rolipram",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "Major Depressive Disorder",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: [C-11]T-1650",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: BPN14770",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "Depression",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E15",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: Roflumilast",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.9,
      "evidence": "Dementia",
      "source_chunk_ids": [
        "d1d78803cacc9bc9b08483215c6f74d0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Drug: MK0952",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "NCT00362024Alzheimer's Disease",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Drug: BPN14770",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "NCT02840279Alzheimer's Disease",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Drug: GSK356278",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "NCT01573819Huntington Disease",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Drug: Roflumilast",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Biological: Istekinumab",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "NCT02835716Alzheimer Disease",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E11",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Drug: Roflumilast",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "NCT02079844Schizophrenia",
      "source_chunk_ids": [
        "4eb58b331d615a8e5d158fc164344840"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: Roflumilast",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Memory Impairment",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Alzheimer's Disease",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: MN-166",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Glioblastoma",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Recurrent Glioblastoma",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: Ibudilast",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Amyotrophic Lateral Sclerosis",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E11",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Drug: Ibudilast",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Migraine Headache",
      "source_chunk_ids": [
        "eeaec1cb48feecba24f0e284790c570b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phase 2",
      "source_chunk_ids": [
        "f2d6b9720a7d4b7d41dfa067697fa3d5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Multiple Sclerosis",
      "source_chunk_ids": [
        "f2d6b9720a7d4b7d41dfa067697fa3d5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.85,
      "evidence": "Primary Progressive",
      "source_chunk_ids": [
        "f2d6b9720a7d4b7d41dfa067697fa3d5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Phase 2 clinical trial",
      "source_chunk_ids": [
        "87dfc626713653a6932ea3f64088d067"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Drug: HT-0712",
      "source_chunk_ids": [
        "87dfc626713653a6932ea3f64088d067"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "studied"
      },
      "confidence": 0.8,
      "evidence": "Age-Associated Memory Impairment (AAMI)",
      "source_chunk_ids": [
        "87dfc626713653a6932ea3f64088d067"
      ],
      "supporting_study_ids": [],
      "verified": true
    }
  ]
}